The 35th CINP World Congress of Neuropsychopharmacology

Sessions

CINP2024 » Poster Session

[CINP2024] Poster Session

Addiction Disorders 1 - Clinical (1)

Fri. May 24, 2024 5:30 PM - 6:30 PM CINP Poster Session Hall (Lobby Gallery)

*Tianzhen Chen1, Haoye Tan2, Hang Su1, Haifeng Jiang1, Min Zhao1 (1. Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China, 2. Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany )

Mauro Pettorruso1,2, Andrea Miuli2, *Francesco Di Carlo1, Gianluca Mancusi1, Katia Clemente3, Stefania Chiappini4, Giacomo d'Andrea1, Giovanni Martinotti1,5 (1. Department of Neuroscience, Imaging and Clinical Sciences, “G. d'Annunzio” University, Chieti, Italy, 2. Department of Mental Health, ASL 2 Abruzzo Lanciano-Vasto-Chieti, Italy, 3. Clinical Pathology Unit, ASL 2 Abruzzo Lanciano-Vasto-Chieti, Italy, 4. Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK, 5. Department of Pharmacy, Pharmacology, Clinical Science, University of Hertfordshire, Herts, UK)

STEFANIA CHIAPPINI1, *CLARA CAVALLOTTO2, GIACOMO D'ANDREA2, ANDREA DI CESARE2, ALESSIO MOSCA2, FRANCESCO DI CARLO2, MAURO PETTORRUSO2, GIOVANNI MARTINOTTI2, FABRIZIO SCHIFANO3 (1. UniCamillus, 2. Department of Neuroscience, Imaging and Clinical Science, University G. D'Annunzio, Chieti, Italy, 3. Department of Clinical and Pharmaceutical Sciences, University of Hertfordshire, Hatfeld, UK )

*Annie Chung1,4, Yen-Feng Lin1,2,3, Ming-Chyi Huang4,5,6 (1. National Health Research Institute, 2. Department of Public Health & Medical Humanities, School of Medicine, National Yang Ming Chiao Tung University, 3. Institute of Behavioral Medicine, College of Medicine, National Cheng Kung University, 4. Department of Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, 5. Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, 6. Psychiatric Research Center, Taipei Medical University Hospital)

*Hideaki Tani1, Ryo Ochi1, Fumihiko Ueno2, Mutsuki Sakuma3, Sakiko Tsugawa1, Hiroyuki Uchida1, Shunji Oshima4, Sachio Matsushita3, Shinichiro Nakajima1 (1. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 2. Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada, 3. National Hospital Organization Kurihama Medical and Addiction Center, Kanagawa, Japan, 4. Sustainable Technology Laboratories, Asahi Quality and Innovations, Ltd., Ibaraki, Japan)

*Muhammad Abdullah1, Shih-Hsien Lin2,3,4, Li-Chung Huang5,6, Huai-Hsuan Tseng3,2, Po See Chen2,3, Yen Kuang Yang7,3,2 (1. Taiwan International Graduate Program in Interdisciplinary Neuroscience, National Cheng Kung University and Academia Sinica, Taipei, Taiwan, 2. Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 3. Institute of Behavioral Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 4. Clinical Medicine Research Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 5. Institute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan, 6. Department of Psychiatry, Chia-Yi Branch, Taichung Veterans General Hospital, Chia-Yi, Taiwan, 7. Department of Psychiatry, Tainan Hospital, Ministry of Health and Welfare, Tainan, Taiwan)

*Yu Chi Hou1, Ming Chyi Huang1,2, Tung Hsia Liu3, Yu Li Liu3 (1. Department of Addiction Sciences, Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan, 2. Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, 3. Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, Miaoli County, Taiwan)

*Hsiang-Wei Kuo1, Tung-Hsia Liu1, Yu-Li Liu1, Ming-Chi Huang2,3 (1. Center for Neuropsychiatric Research, National Health Research Institutes, 2. Department of Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, 3. Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University)

[CINP2024] Poster Session

Addiction Disorders 2 - Translational

Fri. May 24, 2024 5:30 PM - 6:30 PM CINP Poster Session Hall (Lobby Gallery)

*Chang Liu1,2, Jinqiao Li1,2, Na Zeng1,2, Huan Mei1,2, Xiaokun Wang1,2, Shui-Lin Wu1,2, Kai Yuan3, Xiaoxing Liu3, Gang Wang4, Shiqiu Meng1, Qingguo Shi4, Lin Lu1,3,5, Jie Shi1, Yan-Ping Bao1,2 (1. National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, China, 2. School of Public Health, Peking University, Beijing, China, 3. Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health, National Clinical Research Center for Mental Disorders, Beijing, China, 4. Compulsory Isolation Drug Rehabilitation Center in Daxinzhuang, Changzhi, Shanxi Province, China, 5. Peking-Tsinghua Centre for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, China)

*Yasuharu Yamaguchi1,2, Shinya Kasai1,3,4, Junko Hasegawa1, Kazutaka Ikeda1,2 (1. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, JAPAN, 2. Molecular and Cellular Medicine, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JAPAN, 3. Department of Biotechnology, Faculty of Life and Environmental Sciences, University of Yamanashi, Yamanashi, JAPAN, 4. Center for Advanced Assisted Reproductive Technologies, University of Yamanashi, Yamanashi, JAPAN)

[CINP2024] Poster Session

Addiction Disorders 3 - Others

Fri. May 24, 2024 5:30 PM - 6:30 PM CINP Poster Session Hall (Lobby Gallery)

*Tangsheng Lu1, Xue Li1, Xiaoxing Liu2, Wei Zheng3, Yin Han1, Lin Lu3,1,2 (1. National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence Research, Peking University, Beijing, China, 2. Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health, Peking University, Beijing, China , 3. Peking-Tsinghua Centre for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, China )

*CHEN WENBING1, Asano Takashi1, Izuo Notaka1, Muramatsu Shin-ichi 2,3, Nitta Atsumi1 (1. Department of Pharmaceutical Therapy & Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Japan. , 2. Division of Neurological Gene Therapy, Center for Open Innovation, Jichi Medical University, Shimotsuke, Japan. , 3. Center for Gene & Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)

*Min Kyung Hu1,2, Kyeong Seob Song3, Ji-won Chun3, Dai Jin Kim1,2 (1. Department of Biomedicine & Health Sciences, The Catholic University of Korea College of Medicine, Seoul, KOREA, 2. Department of Psychiatry, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, KOREA, 3. Department of Medical Informatics, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea.)

[CINP2024] Poster Session

Anxiety Disorders

Fri. May 24, 2024 5:30 PM - 6:30 PM CINP Poster Session Hall (Lobby Gallery)

*Rafael Freire1,2,3, Marcos Fidry3, Morena Zugliani3, Mariana Cabo3, Clara Faria3, Antonio Nardi3 (1. Department of Psychiatry and Centre for Neuroscience Studies, Queen's University, Kingston, Ontario, Canada, 2. Kingston General Hospital Research Institute, Kingston Health Sciences Centre, Kingston, Canada, 3. Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil)

Saki Kamiyama1, *Saeko Ikai-Tani2,3,4, Mirai So1, Hiroyuki Uchida2 (1. Department of Psychiatry, Tokyo Dental College, Chiba, Japan, 2. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 3. Faculty of Kinesiology and Physical Education, University of Toronto, Toronto, Canada, 4. Department of Psychiatry, Minami-Hanno Hospital, Saitama, Japan)

*NOBUYUKI MITSUI MITSUI1, Yutaka Fujii2, Satoshi Asakura1, Hissei Imai3, Hisashi Yamada4, Naoki Yoshinaga5, Yoshihiro Kanai6, Takeshi Inoue7, Eiji Shimizu8 (1. Department of Psychiatry, Graduate School of Medicine, Hokkaido University, Hokkaido, Japan, 2. Department of Psychiatry, Houyougaoka Hospital, Hokkaido, Japan, 3. Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine and School of Public Health, Kyoto, Japan, 4. Department of Neuropsychiatry, Hyogo College of Medicine, Hyogo, Japan, 5. School of Nursing, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan, 6. Department of Human Science, Faculty of Liberal Arts, Tohoku Gakuin University, Sendai, Japan, 7. Department of Psychiatry, Tokyo Medical University, Tokyo, Japan, 8. Cognitive Behavioral Therapy Center, Chiba University Hospital, Chiba, Japan)

*Yi Li1, Dong-Dong Shi1,2, Zhen Wang1,2,3 (1. Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China, 2. Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China, 3. Institute of Psychological and Behavioral Science, Shanghai Jiao Tong University, Shanghai, China)

*Ying-Dan Zhang1, Dong-Dong Shi1,2, Sen Zhang2, Zhen Wang1,2,3 (1. Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China., 2. Shanghai Key Laboratory of Psychotic disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China., 3. Institute of Psychological and Behavioral Science, Shanghai Jiao Tong University, Shanghai, China)

*Karin Nakahara1, Akihiro Mouri1,2, Kazuo Kunisawa1, Masaya Hasegawa1, Toshitaka Nabeshima2,3 (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Sciences, Aichi, Japan., 2. Japanese Drug Organization of Appropriate Use and Research (J-DO), Aichi, Japan. , 3. Laboratory of Health and Medical Science Innovation, Fujita Health University Graduate School of Health Science, Aichi, Japan.)

*Yurie Nakamoto1, Mio Kaga2, Seiji Kawana2, Kazuhiko Nakamura3, Kazutaka Ikeda1, Mitsunobu Yoshii1 (1. Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo Japan, 2. Department of Dermatology, Nippon Medical School, Tokyo, Japan, 3. Department of Neuropsychiatry, Hirosaki University School of Medicine, Aomori, Japan)

[CINP2024] Poster Session

Attention Deficit Disorders

Fri. May 24, 2024 5:30 PM - 6:30 PM CINP Poster Session Hall (Lobby Gallery)

*Nisha Ravindran1, Michael Van Ameringen2, Beth Patterson3, Juliette Mojgani4, J. Turna5, C. Goldman Bergman6, Angela Paric7, Annette Kowara8, Arun Ravindran9 (1. University of Toronto, 2. McMaster University, 3. McMaster University , 4. McMaster University , 5. McMaster University , 6. McMaster University , 7. University of Toronto , 8. University of Toronto , 9. University of Toronto )

*Hiroki Shikanai1,2, Naoya Suzuki1, Satoshi Shinozuka1, Takeru Isshiki1, Sachiko Hiraide1, Kenji Iizuka1, Takeshi Izumi1,2, Taku Yamaguchi3 (1. Department of Pharmacology, Faculty of Pharmaceutical Sciences, Health Science University of Hokkaido, Hokkaido, Japan, 2. Advanced Research Promotion Center, Health Science University of Hokkaido, Hokkaido, Japan, 3. Department of Pharmacotherapeutics and Neuropsychopharmacology, Faculty of Pharmaceutical Science, Nagasaki International University, Nagasaki, Japan)

[CINP2024] Poster Session

Bipolar Disorders (1)

Fri. May 24, 2024 5:30 PM - 6:30 PM CINP Poster Session Hall (Lobby Gallery)

*Keita Tokumitsu1, Norio Yasui-Furukori1,2, Naoto Adachi3, Yukihisa Kubota3, Yoichiro Watanabe3, Kazuhira Miki3, Takaharu Azekawa3, Koji Edagawa3, Eiichi Katsumoto3, Seiji Hongo3, Eiichiro Goto3, Hitoshi Ueda3, Masaki Kato2,4, Atsuo Nakagawa2,5, Toshiaki Kikuchi2,6, Takashi Tsuboi2,7, Koichiro Watanabe2,7, Kazutaka Shimoda1,2, Reiji Yoshimura2,8 (1. Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan, 2. The Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan, 3. The Japanese Association of Neuro-Psychiatric Clinics, Tokyo, Japan, 4. Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan, 5. Department of Neuropsychiatry, St. Marianna University School of Medicine, Kanagawa, Japan, 6. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 7. Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan, 8. Department of Psychiatry, University of Occupational and Environmental Health, Fukuoka, Japan)

*Johnny (Chun Hui) Park1, Melanie Ashton1, Judy Hope2, Chee Ng3, Malcolm Hopwood4, Jon-Paul Khoo1,5, Gin Malhi6,7, Brisa Fernandes8, Stella May Gwini9, John Amerena10, Trisha Suppes11,12, Mary Lou Chatterton2, Lana Williams1, Adam Walker1, Alyna Turner1, Andre Carvalho1, Andrew Nierenberg13, Emily Moriaty1, Lars Kessing14,15, Mohammedreza Mohebbi16, Seetal Dodd1, Steven Moylan1, Jose Segal2, John Tiller4, Joel King3, Jeremy Couper2, Jee Hyun Kim1,17, Olivia Dean1,17, Michael Berk1,17,18,19 (1. Deakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia , 2. Monash University, Eastern Health and Centre of Mental Health Education and Research at Delmont Private Hospital, Melbourne, VIC, Australia, 3. The Melbourne Clinic, Department of Psychiatry, University of Melbourne, 130 Church St, Richmond, Australia, 4. Department of Psychiatry, University of Melbourne, Professorial Psychiatry Unit, Albert Road Clinic, Melbourne, Australia, 5. Faculty of Medicine, The University of Queensland, Brisbane QLD, Australia, 6. Discipline of Psychiatry, Sydney Medical School, University of Sydney, Sydney, Australia, 7. CADE Clinic, Department of Psychiatry, Royal North Shore Hospital, St. Leonards, Australia, 8. Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA, 9. University Hospital Geelong, Department of Research, Geelong, Victoria, Australia, 10. University Hospital Geelong, Geelong, VIC, 11. Bipolar and Depression Research Program, VA Palo Alto Health Care System, 3801 Miranda Avenue (151T), Palo Alto, CA, 94304, USA, 12. Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA, 94305, USA, 13. The Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA, 14. Copenhagen Affective Disorders Research Centre (CADIC), Psychiatric Center Copenhagen, Rigshospitalet, and Faculty of Health and Medical Sciences, 15. University of Copenhagen, 6243, Rigshospitalet. Blegdamsvej 9, 2100 Copenhagen, Denmark, 16. Biostatistics Unit, Faculty of Health, Deakin University, Burwood, Australia, 17. Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Australia, 18. Department of Psychiatry, University of Melbourne, Parkville, Australia, 19. Orygen, National Centre of Excellence in Youth Mental Health, Parkville, Australia)

*YUNA KIM1, Yun Seong Park1, Jaehyun Kim2,3, Yoonjeong Jang1,4, Woojae Myung1,5 (1. Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, South Korea, 2. Department of Clinical Medical Sciences, Seoul National University, College of Medicine, Seoul, South Korea, 3. Department of Psychiatry, Korea Army Training Center District Hospital, Nonsan, South Korea, 4. Department of Health Science and Technology, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea, 5. College of Medicine, Seoul National University, Seoul, South Korea)

*Wen Yin Chen1,2, Chih Chiang Chiu1,3, Po-Hsiu Kuo4,5,6, Cho-Yin Huang1,4, Chian-Jue Kuo1,3, Po-Yu Chen1,3, Ming-Chyi Huang1,3 (1. Department of Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan, 2. School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei, Taiwan, 3. Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, 4. Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan, 5. Department of Public Health, College of Public Health, National Taiwan University, Taipei, Taiwan, 6. Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan)

*YUANZHI HSUEH1, Cho-Yin Huang1,2, Po-Hsiu Kuo2,5,6, Ying-Chih Cheng2,4, Ming-Chyi Huang1,3, Chih Chiang Chiu1,3, Chian-Jue Kuo1,3, Po-Yu Chen1,3, Wen-Yin Chen1,2,7 (1. Department of Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan, 2. Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan, 3. Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, 4. Department of Psychiatry, China Medical University Hsinchu Hospital, China Medical University, Hsinchu, Taiwan, 5. Department of Public Health, College of Public Health, National Taiwan University, Taipei, Taiwan, 6. Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan, 7. School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei, Taiwan)

[CINP2024] Poster Session

COVID-19

Fri. May 24, 2024 5:30 PM - 6:30 PM CINP Poster Session Hall (Lobby Gallery)

*Yu-Li Liu1, Tung-Hsia Liu1, Chih-Hui Wang1, Hsiang-Wei Kuo1, Shiu-Feng Huang2, Hsiao-Hui Tsou3, Wei J. Chen1 (1. Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli County, Taiwan, 2. Institute of Molecular and Genomic Medicine, National Health Research Institutes, 3. Institute of Population Health Sciences, National Health Research Institutes, Miaoli, Taiwan)

*Tung-Hsia Liu1, Chih-Hui Wang1, Shiu-Feng Huang2, Hsiao-Hui Tsou3,4, Guann-Yi Yu5, Andrew C.H. Chen6,7, Wei J. Chen1, Yu-Li Liu1 (1. Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli County, Taiwan, 2. Institute of Molecular and Genomic Medicine, National Health Research Institutes, 3. Institute of Population Health Sciences, National Health Research Institutes, Miaoli, Taiwan, 4. Graduate Institute of Biostatistics, College of Public Health, China Medical University, Taichung, Taiwan, 5. National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan, 6. Department of Psychiatry, Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York, USA, 7. Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA)

*M. Mercedes Perez-Rodriguez1, Sahana Prakash1, Kendall Moore1, Juliana Camacho-Castro1, Whitney Lieb1, Rebecca Jessel1, Frederieke Gigase1, Corina Lesseur1, Teresa Janevic1, Siobhan Dolan2, Joanne Stone1, Lotje de Witte1, Veerle Bergink1, Anna-Sophie Rommel1 (1. Icahn School of Medicine at Mount Sinai, 2. Stamford Health)

*Rene Hurlemann1, Ruben Berger2, Simone Shamay-Tsoory3, Alisa Kanterman3, Maura Brausa2, Jessica Gorni2, Maike Luhmann4, Elisabeth Schramm5, Johannes Schultz6, Alexandra Philipsen2, Jana Lieberz7, Dirk Scheele8 (1. Department of Psychiatry and Psychotherapy, School of Medicine and Health Sciences, University of Oldenburg, Oldenburg, Germany, 2. Department of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germany, 3. Department of Psychology, University of Haifa, Haifa, Israel, 4. Department of Psychological Methods, Faculty of Psychology, Ruhr-University Bochum, Bochum, Germany, 5. Department of Psychiatry and Psychotherapy, University of Freiburg Medical Center, University of Freiburg, Freiburg, Germany, 6. Center for Economics and Neuroscience, University of Bonn, Bonn, Germany, 7. Medical Psychology Section, Department of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germany, 8. Department of Medical Psychology and Medical Sociology, Faculty of Medicine, Ruhr-University Bochum, Bochum)

[CINP2024] Poster Session

Depression 1 - Clinical (1)

Fri. May 24, 2024 5:30 PM - 6:30 PM CINP Poster Session Hall (Lobby Gallery)

*Yosuke Kameno1,2, Masamichi Yokokura1,2, Toshiki Iwabuchi2,3, Chihiro Murayama1, Takafumi Goto1, Taishi Tamayama1, Tomoyasu Wakuda1, Seico Benner1,4, Yasuomi Ouchi5,6, Hidenori Yamasue1,2 (1. Department of Psychiatry, Hamamatsu University School of Medicine, Shizuoka, Japan, 2. United Graduate School of Child Development, Hamamatsu University School of Medicine, Shizuoka, Japan, 3. Research Center for Child Mental Development, Hamamatsu University School of Medicine, Shizuoka, Japan, 4. Center for Health and Environmental Risk Research, National Institute for Environmental Studies, Ibaraki, Japan, 5. Department of Biofunctional Imaging, Hamamatsu University School of Medicine, Shizuoka, Japan, 6. Hamamatsu Medical Imaging Center, Hamamatsu Medical Photonics Foundation, Shizuoka, Japan)

*Yasmin Harrington1,2, Elisa Melloni2, Melania Maccario1,3, Marco Paolini1,2, Lidia Fortaner Uyà1,2, Sara Poletti1,2, Raffaella Zanardi1,3, Francesco Benedetti 1,2 (1. Vita Salute San Raffaele University, Milan, Italy , 2. Psychiatry & Clinical Psychobiology, Division of Neuroscience, IRCCS Scientific Institute Ospedale San Raffaele, Milan, Italy, 3. Mood Disorders Unit, Scientific Institute IRCCS Ospedale San Raffaele, Milan, Italy)

*Jong-Hoon Kim1,2, Yo-Han Joo2, Jeong-Hee Kim2,3, Young-Don Son2,3,4 (1. Department of Psychiatry, Gachon University College of Medicine, Gil Medical Center, Gachon University, Incheon, Korea, Republic of, 2. Neuroscience Research Institute, Gachon University, Incheon, Korea, Republic of, 3. Biomedical Engineering Research Center, Gachon University, Incheon, Korea, Republic of, 4. Department of Biomedical Engineering, College of IT Convergence, Gachon University, Seongnam-si, Korea, Republic of)

*Weili XIA1, Minxia JIN1,2, Ping QIN1, Laidi KAN1, Bingbing ZHANG1, Tim T.Z. LIN1, Ami S.M. LI1, Georg S. KRANZ1,3,4 (1. Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong SAR, China, 2. Shanghai YangZhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), School of Medicine, Tongji University, Shanghai, China, 3. Mental Health Research Center (MHRC), The Hong Kong Polytechnic University, Hong Kong, China, 4. Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria)

*Minxia JIN1,2, Penny Ping QIN1, Adam Wei li XIA1, Rebecca Lai di KAN1, Bella Bing bing ZHANG1, Alvin Hong pui TANG1, Ami Sin man LI1, Tim Tian ze LIN1, Jun jie PEI3, Georg S Kranz1,4,5 (1. Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong, Chine, 2. Shanghai YangZhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), School of Medicine, Tongji University, Shanghai, China, 3. Department of Rehabilitation Medicine, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, China, 4. Mental Health Research Center, The Hong Kong Polytechnic University, Hong Kong, China, 5. Department of Psychiatry and Psychotherapy, Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Austria)

*Bella bingbing ZHANG1, Levi Teng Liu1, Rebecca Laidi Kan1, Minxia Jin1,2, Adam Weili Xia1, Penny Ping Qin1, Tim Tianze Lin1, Alvin H.P. Tang1, Ami S.M. Li1, Kenneth N.K. Fong1, Georg S. Kranz1,3,4 (1. Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong SAR, China, 2. Shanghai YangZhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), School of Medicine, Tongji University, Shanghai, China, 3. Mental Health Research Center (MHRC), The Hong Kong Polytechnic University, Hong Kong SAR, China, 4. Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria)

*Po See Chen1,2, Chin Wei Yek1, Tsung-Hua Lu2, Tzu-Yun Wang2, Wei Hung Chang1,3, Huai-Hsuan Tseng1,2 (1. Institute of Behavioral Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 2. Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 3. Department of Psychiatry, National Cheng Kung University Hospital, Dou-Liou Branch, Yunlin, Taiwan)

*Xiangyang Zhang2,3, Xingxing Li1,2,3, Junyao Liu2,3, Shuochi Wei1, Chang Yu1, Dongmei Wang2,3, Yuchen Li1, Jiaxin Li2,3, Wenhao Zhuang1, Rui-Chen-Xi Luo1, Yanli Li1, Zhiwang Liu1, Yuqiu Su1, Jimeng Liu1, Yongming Xu1, Jialin Fan4, Guidong Zhu4, Weiqian Xu5, Yiping Tang5, Hui Yan5, Raymond Y. Cho6, Thomas R. Kosten6, Dong-Sheng Zhou1 (1. Ningbo Kangning Hospital & Affiliated Mental Health Centre, Ningbo University, Ningbo Key Laboratory for Physical Diagnosis and Treatment of Mental and Psychological Disorders, Ningbo, Zhejiang, China, 2. CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing, China, 3. Department of Psychology, University of Chinese Academy of Sciences, Beijing, China., 4. The Second People’s Hospital of Lishui, Lishui, Zhejiang, China., 5. Taizhou Second People's Hospital, Taizhou, Zhejiang, China., 6. Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, United States)

*Lidia Fortaner-Uyà1,2, Federica Colombo1,2, Federico Calesella1,2, Camilla Monopoli2, Emma Tassi3,4, Eleonora Maggioni4, Paolo Brambilla3, Chiara Fabbri5, Alessandro Serretti5, Francesco Benedetti1,2, Benedetta Vai1,2 (1. University Vita-Salute San Raffaele, Milan, Italy, 2. IRCCS San Raffaele Hospital, Psychiatry and Clinical Psychobiology Unit - Division of Neuroscience, Milan, Italy, 3. Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Department of Neurosciences and Mental Health, Milan, Italy, 4. Politecnico di Milano, Department of Electronics - Information and Bioengineering, Milan, Italy, 5. University of Bologna, Department of Biomedical and Neuromotor Sciences, Bologna, Italy)

[CINP2024] Poster Session

Depression 2 - Preclinical (1)

Fri. May 24, 2024 5:30 PM - 6:30 PM CINP Poster Session Hall (Lobby Gallery)

*Leonard Lerer1, Katherine Spear1, Jeet Varia1, Cecily Keim1, Alex Buko2, Karin Blakolmer1, Bernard Lerer3 (1. Back of the Yards Algae Sciences - Parow Entheobiosciences, Chicago, IL, United States, 2. Human Metabolome Technologies, Boston, MA, United States, 3. Hadassah BrainLabs - Center for Psychedelic Research, Hadassah Medical Center, Hebrew University, Jerusalem, Israel)

*Naoto KAJITANI1,2,3, Mami OKADA-TSUCHIOKA3, Asuka INOUE4, Kanako MIYANO5,6, Takeshi MASUDA7, Shuken BOKU1, Kazuya IWAMOTO8, Sumio OHTSUKI7, Yasuhito UEZONO5, Junken AOKI9, Minoru TAKEBAYASHI1,3 (1. Department of Neuropsychiatry, Faculty of Life Sciences, Kumamoto University, 2. Center for Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, 3. Division of Psychiatry and Neuroscience, Institute for Clinical Research, National Hospital Organization Kure Medical Center, 4. Laboratory of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, 5. Department of Pain Control Research, The Jikei University School of Medicine, 6. Division of Cancer Pathophysiology, National Cancer Center Research Institute, 7. Department of Pharmaceutical Microbiology, Faculty of Life Sciences, Kumamoto University, 8. Department of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, 9. Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo)

*Yaxin Sun1, Yun-ai Su1, Qi Wang1,2, Jiaya Zheng1,2, Chenchen Zhang1,2, Ting Wang1, Xiao Liu1, Yunu Ma1, Xuexin Li1, Xianqiang Zhang1, Xiaomeng Xie1, Xiaodong Wang3, Jitao Li1, Tianmei Si1,2 (1. Peking University Sixth Hospital, Peking University Institute of Mental Health, Beijing, China, 2. Institute of Mental Health, Wenzhou Medical University, 325035 Wenzhou, China, 3. Department of Neurobiology, Key Laboratory of Medical Neurobiology of Ministry ofHealth of China, Zhejiang Province Key Laboratory of Neurobiology, Hangzhou, China)

*Wataru Ukai1, Kenta Deriha1,4, Emi Nishimura1, Eri Hashimoto1, Misa Yamada5, Hanako Hashiguchi1, Shoma Hirose1,4, Marina Mochizuki1,6, Yukihiko Momoki1, Kengo Furuse1,6, Takao Ishii1,2, Kanna Nagaishi3, Marco A. Riva7, Chiaki Kawanishi1 (1. Dept. of Neuropsychiatry, Sapporo Medical Univ., Sapporo, Japan, 2. Dept. of Occupational Therapy, Sapporo Medical Univ., Sapporo, Japan, 3. Dept. of Anatomy II, Sapporo Medical Univ., Sapporo Japan, 4. Dept. of Psychiatry, Sunagawa City Hospital, Sunagawa, Japan, 5. Dept. of Neuropsychopharmacology, NIMH, NCNP, Tokyo, Japan, 6. Dept. of Psychiatry, Obihirokosei Hospital, Obihiro, Japan, 7. Dept. of Pharmacological & Biomolecular Science, Univ. of Milan, Milan, Italy)

*Martin Kuchar1, Klara Gotwaldova1, Jan Borovicka2, Radek Jurok3, Petra Cihlarova1, Katerina Hajkova1 (1. Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry nad Technology Prague, 2. Institute of Geology of the Czech Academy of Sciences, 3. Department of Organic Chemistry, University of Chemistry nad Technology Prague)

*Rei Yokoyama1, Yukio Ago2, Hisato Igarashi1, Momoko Higuchi1, Masato Tanuma1, Yuto Shimazaki1, Kaoru Seiriki1, Misuzu Hayashida1, Shun Yamaguchi3,4, Hirokazu Tanaka5, Takanobu Nakazawa6, Kenji Hashimoto7, Atsushi Kasai1,8, Hitoshi Hashimoto1,9,10,11,12 (1. Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 2. Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan, 3. Department of Morphological Neuroscience, Graduate School of Medicine, Gifu University, Gifu, Japan, 4. Center for One Medicine Innovative Translational Research, Institute for Advanced Study, Gifu University, Gifu, Japan, 5. Faculty of Information Technology, Tokyo City University, Tokyo, Japan, 6. Department of Bioscience, Tokyo University of Agriculture, Tokyo, Japan, 7. Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan, 8. Systems Brain Science Project, Drug Innovation Center, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 9. Molecular Research Center for Children’s Mental Development, United Graduate School of Child Development, Osaka University, Osaka, Japan, 10. Division of Bioscience, Institute for Datability Science, Osaka University, Osaka, Japan, 11. Open and Transdisciplinary Research Initiatives, Osaka University, Osaka, Japan, 12. Department of Molecular Pharmaceutical Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan)

*Puji Rizki Suryani1, Eka Febri Zulissetiana2, Bintang Arroyantri Prananjaya1, Syarifah Aini1, Diyaz Syauki Ikhsan1 (1. Department of Psychiatry, Medical Faculty, Universitas Sriwijaya, Palembang, Indonesia, 2. Department of Physiology, Medical Faculty, Universitas Sriwijaya, Palembang, Indonesia)

[CINP2024] Poster Session

Epilepsy

Fri. May 24, 2024 5:30 PM - 6:30 PM CINP Poster Session Hall (Lobby Gallery)

*Putri Nugraheni1, Attaufiq Irawan 2, Almerveldy Azaria Dohong3, Adelina Dwi Putri1, Ahmad Rafi Faiq4 (1. Department of Psychiatry, Pelabuhan Jakarta Hospital, Jakarta, Indonesia, 2. Vila Medika Clinic, South Tangerang, Indonesia., 3. Pembangunan Nasional “Veteran” University, Jakarta, Indonesia, 4. Pondok Indah Bintaro Jaya Hospital, South Tangerang, Indonesia)

*Yukino Ishizaka1, Akihiro Mouri1,5, Kazuo Kunisawa1, Takaya Nishikawa1, Tomoyuki Furuyashiki2, Shuh Narumiya3, Toshitaka Nabeshima4,5 (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Sciences, Aichi, Japan., 2. Division of Pharmacology, Graduate School of Medicine, Kobe University, Hyogo, Japan., 3. Department of Drug Discovery Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., 4. Laboratory of Health and Medical Science Innovation, Fujita Health University Graduate School of Health Science, Aichi, Japan., 5. Japanese Drug Organization of Appropriate Use and Research (J-DO), Aichi, Japan.)

[CINP2024] Poster Session

Schizophrenia 1 - Clinical (1)

Fri. May 24, 2024 5:30 PM - 6:30 PM CINP Poster Session Hall (Lobby Gallery)

*Dongmei Wang1,2, Xijing Chen1,2, Yang Tian1,2, Zhixuan Yu1,2, Dachun Chen3, Meihong Xiu3, Thomas Kosten4,5, Xiangyang Zhang1,2 (1. CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing, China, 2. Department of Psychology, University of Chinese Academy of Sciences, Beijing, China, 3. Beijing HuiLongGuan Hospital, Peking University, Beijing, China, 4. Mental Health Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA, 5. Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas, USA)

*Tatsuro Marumoto1, Yosuke Saga1, Hiroaki Kinoshita2, Natsuko Morita2, Tokiko Touma3, Shinya Wakamatsu1, Kyoko Takebe2, Akihide Wakamatsu1, Chih-Lin Chiang1 (1. Medical Affairs Division, Janssen Pharmaceutical K.K., 2. Drug Safety Surveillance Department, Japan Safety & Surveillance Division, Janssen Pharmaceutical K.K., 3. Statistics & Decision Sciences Japan, Janssen Pharmaceutical K.K.)

*Tatsuro Marumoto1, Hiroshi Horio1, Hiroaki Kinoshita2, Natsuko Morita2, Tokiko Touma3, Kyoko Takebe2, Akihide Wakamatsu1 (1. Medical Affairs Division, Janssen Pharmaceutical K.K., 2. Drug Safety Surveillance Department, Japan Safety & Surveillance Division, Janssen Pharmaceutical K.K., 3. Statistics & Decision Sciences Japan, Janssen Pharmaceutical K.K.)

*Shinichiro Ochi1, Fumitoshi Kodaka2, Naomi Hasegawa3, Jun-ichi Iga1, Hiroko Kashiwagi3, Hiroshi Komatsu4, Hiromi Tagata5, Takashi Tsuboi6, Shusuke Numata7, Hitoshi Iida8, Shun Igarashi6, Kazutaka Ohi9, Kentaro Fukumoto10, Hiroyuki Muraoka11, Junya Matsumoto3, Kenichiro Miura3, Shu-ichi Ueno1, Koichiro Watanabe6, Ken Inada11, Ryota Hashimoto3, Norio Yasui-Furukori12 (1. Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, Ehime, Japan, 2. Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan, 3. Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan, 4. Department of Psychiatry, Tohoku University Hospital, Miyagi, Japan, 5. Department of Neuropsychiatry, Toho University School of Medicine, Tokyo Japan, 6. Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan, 7. Department of Psychiatry, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan, 8. Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan, 9. Department of Psychiatry, Gifu University Graduate School of Medicine, Gifu, Japan, 10. Department of Neuropsychiatry, School of Medicine, Iwate Medical University, Iwate, Japan, 11. Department of Psychiatry, Kitasato University, School of Medicine, Kanagawa, Japan, 12. Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan)

*Chian-Jue Kuo1,2,3, Wen-Yin Chen1,4, Pao-Huan Chen2,3, Shang-Ying Tsai2,3, Chiao-Chicy Chen2,3,5,6 (1. Taipei City Psychiatric Center, Taipei City Hospital, 2. Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, 3. Psychiatric Research Center, Taipei Medical University Hospital, Taipei, Taiwan, 4. School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan, 5. Department of Psychiatry, Mackay Memorial Hospital, Taipei, Taiwan, 6. Department of Psychiatry, Mackay Medical College, Taipei, Taiwan)

*Naoki Hashimoto1, Norio Yasui-Furukori2, Naomi Hasegawa3, Hikaru Hori4, Hitoshi Iida4, Kayo Ichihashi5, Kenichiro Miura3, Junya Matsumoto3, Shusuke Numata6, Fumitoshi Kodaka7, Ryuji Furihata8, Ken Inada9, Koichiro Watanabe10, Ryota Hashimoto3 (1. Department of Psychiatry, Hokkaido University Graduate School of Medicine, Hokkaido, Japan, 2. Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan, 3. Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan, 4. Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan, 5. Department of Neuropsychiatry, University of Tokyo Hospital, Tokyo, Japan, 6. Department of Psychiatry, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan, 7. Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan, 8. Agency for Student Support and Disability Resources, Kyoto University, Kyoto, Japan, 9. Department of Psychiatry, Kitasato University School of Medicine, Kanagawa, Japan, 10. Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan)

*Bintang Arroyantri Prananjaya1, Miranti Dwi Hartanti2, Ziske Maritska Maritska3, Mgs Irsan Saleh Hasani4 (1. Department of Psychiatry, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia, 2. Department of Pharmacology, Faculty of Medicine, Universitas Muhammadiyah Palembang, Palembang, Indonesia, 3. Department of Biology Medicine, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia, 4. Department of Pharmacology, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia)

*Kazutaka Ohi1,2, Mihoko Shimada3, Midori Soda4, Daisuke Nishizawa5, Daisuke Fujikane1, Kentaro Takai1, Ayumi Kuramitsu1, Yukimasa Muto1, Shunsuke Sugiyama1, Junko Hasegawa5, Kiyoyuki Kitaichi4, Kazutaka Ikeda5, Toshiki Shioiri1 (1. Department of Psychiatry, Gifu University Graduate School of Medicine, Gifu, Japan, 2. Department of General Internal Medicine, Kanazawa Medical University, Ishikawa, Japan, 3. Genome Medical Science Project (Toyama), National Center for Global Health and Medicine (NCGM), Tokyo, Japan, 4. Laboratory of Pharmaceutics, Department of Biomedical Pharmaceutics, Gifu Pharmaceutical University, Gifu, Japan, 5. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan)

[CINP2024] Poster Session

Schizophrenia 2 -Preclinical

Fri. May 24, 2024 5:30 PM - 6:30 PM CINP Poster Session Hall (Lobby Gallery)

*Akira Yoshimi1,2, Susumu Y Imanishi3, Tomoya Oguchi1, Shinji Kitagaki4, Norio Ozaki5, Yukihiro Noda1,2 (1. Division of Clinical Sciences and Neuropsychopharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 2. Clinical OMICs and Translation Research Center, Meijo University, Nagoya, Japan, 3. Laboratory of Analytical Chemistry, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 4. Laboratory of Medicinal Chemistry, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 5. Pathophysiology of Mental Disorders, Nagoya University Graduate School of Medicine, Nagoya, Japan)

*Yosefu Arime1, Yoshito Saitoh1, Yasuo Uchida2, Mikiko Ishikawa1, Chikako Kamiyoshihara1, Kazuki Fujii3,4,5, Keizo Takao3,4,5, Noriaki Ohkawa1 (1. Division for Memory and Cognitive Function, Research Center for Advanced Medical Science, Comprehensive Research Facilities for Advanced Medical Science, Dokkyo Medical University, 2. Division of Membrane Transport and Drug Targeting, Graduate School of Pharmaceutical Sciences, Tohoku University, 3. Department of Behavioral Physiology, Faculty of Medicine, University of Toyama, 4. Life Science Research Center, University of Toyama, 5. Research Center for Idling Brain Science, University of Toyama)

*Shunya Kawai1, Akira Yoshimi1,2, Ayaka Kato1, Mizuki Uchida1, Shinji Kitagaki3, Norio Ozaki4, Yukihiro Noda1,2 (1. Division of Clinical Sciences and Neuropsychopharmacology, Meijo University, Faculty and Graduate School of Pharmacy, Nagoya, Japan, 2. Clinical OMICs and Translation Research Center, Meijo University, Nagoya, Japan, 3. Laboratory of Medicinal Chemistry, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 4. Pathophysiology of Mental Disorders, Nagoya University Graduate School of Medicine, Nagoya, Japan)

*Greg Stewart1,2, Yao Lu1, Sheng Yu Ang1,2, Daisy Spark2,3, Juulke Castelijn2,3, Trang Pham2,4, Michelle Camerino2,4, Monica Langiu1, Natalie Diepenhorst1, Clotilde Mannoury La Cour5, Leonid Churilov6, Jess Nithianantharajah2,3, Chris Langmead1,2 (1. Drug Discovery Biology, Neuromedicines Discovery Centre, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia, 2. Phrenix Therapeutics, Parkville, Victoria, Australia, 3. The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia, 4. Australian Translational Medicinal Chemistry Facility, Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia, 5. Les Laboratoires Servier, Suresnes, Paris, France, 6. Melbourne Medical School, The University of Melbourne, Parkville, Victoria, Australia)

*Hana Walaska1, Michal Maryska1,2, Lucie Svobodova1, Wim Dehaen3, Martin Kuchar1,2 (1. Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, Faculty of Food and Biochemical Technology, UCT Prague, Technická 5, 16628 Prague, Czech Republic, 2. National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic, 3. CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Department of Informatics and Chemistry, Faculty of Chemical Technology, UCT Prague, Technická 5, 16628 Prague, Czech Republic)

*Ami Ono1, Daichi Koan1, Satoshi Asano1, Tatsunori Miyaoka2, Lu Chen2, Shinsaku Nakagawa2, Atsuko Hayata-Takano3,4, Takanobu Nakazawa5, Akihiro Harada6, Hitoshi Hashimoto2,4,6, James A Waschek7, Kotaro Tanimoto1, Yukio Ago1 (1. Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan, 2. Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 3. Graduate School of Dentistry, Osaka University, Osaka, Japan, 4. United Graduate School of Child Development, Osaka University, Osaka, Japan, 5. Department of Bioscience, Tokyo University of Agriculture, Tokyo, Japan, 6. Graduate School of Medicine, Osaka University, Osaka, Japan, 7. Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, CA, USA)

*Fumika Ando1, Akihiro Mouri1,2, Kazuo Kunisawa1, Shuhei Yamagishi1, Yuji Komaki3, Kazuki Takano4, Toshitaka Nabeshima2,5 (1. Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University Graduate School of Health Sciences, Aichi, Japan., 2. Japanese Drug Organization of Appropriate Use and Research (J-DO), Aichi, Japan., 3. Central Institute for Experimental Animals (CIEA), 4. Department of Molecular Imaging, Fujita Health University Graduate School of Health Sciences., 5. Laboratory of Health and Medical Science Innovation, Fujita Health University Graduate School of Health Science, Aichi, Japan.)

[CINP2024] Poster Session

Clinical - Others (1)

Fri. May 24, 2024 5:30 PM - 6:30 PM CINP Poster Session Hall (Lobby Gallery)

*Pornjira Pariwatcharakul1, Patipon Homhual2, Punyisa Prachgosin1, Naratip Sa-guanpanich3, Pitchaporn Liao4, Thanarat Suansanae5 (1. Department of Psychiatry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 2. Chalong Hospital, Muang, Phuket, Thailand, 3. Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 4. Biopsychology BS Program, Tufts University School of Arts and Sciences, Tufts University, Medford, Massachusetts, USA, 5. Division of Clinical Pharmacy, Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand)

Muhammad Abdullah1, Shih-Hsien Lin2,3, Li-Chung Huang4, Po See Chen2,3, Huai-Hsuan Tseng2,3, *Yen Kuang Yang2,3,5 (1. Taiwan International Graduate Program in Interdisciplinary Neuroscience, National Cheng Kung University and Academia Sinica, Taipei, Taiwan, 2. Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 3. Institute of Behavioral Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 4. Institute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan, 5. Department of Psychiatry, Tainan Hospital, Ministry of Health and Welfare, Tainan, Taiwan)

*Masanobu Ito1, Taku Hatano2, Junko Horie1, Narimasa Katsuta1, Genko Oyama2, Haruka Takeshige-Amano2, Takashi Ogawa2, Fuyuko Sasaki2, Yasushi Shimo3, Atsushi Umemura4, Hirokazu Iwamuro4, Koji Kamagata5, Atsushi Nakanishi5, Shigeki Aoki5, Nobutaka Hattori2, Takafumi Kato1 (1. Department of Psychiatry, Juntendo University Faculty of Medicine, Tokyo, Japan, 2. Department of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan, 3. Department of Neurology, Juntendo University Nerima Hospital, Tokyo, Japan, 4. Department of Neurosurgery, Faculty of Medicine, Juntendo University, Tokyo, Japan, 5. Department of Radiology, Faculty of Medicine, Juntendo University, Tokyo, Japan)

*Dunja Degmecic1,2, Ivana Jelinčić1,3,2, Marta Balog1, Zeljka Korade4, Karoly Mirnics5, Marija Heffer1, Andrijana Šantić1,2 (1. Faculty of medicine University J.J.Strossmayer Osijek, Croatia, 2. Psychiatric Clinic Clinical Hospital Centre Osijek, Croatia, 3. Faculty for dental medicine and health University J.J.Strossmayer Osijek, Croatia, 4. Department of Pediatrics, University of Nebraska Medical Center USA, 5. Munroe- Meyer Institute, University of Nebraska Medical Center USA)

Andrijana Šantić1,2, Ivana Jelinčić1,2,3, Marta Balog1, Zeljka Korade4, Karoly Mirnics5, Marija Heffer1, *Dunja Degmecic1,2 (1. Faculty of medicine University J.J.Strossmayer Osijek, Croatia, 2. Psychiatric Clinic Clinical Hospital Centre Osijek, Croatia, 3. Faculty for dental medicine and health University J.J.Strossmayer Osijek, Croatia, 4. Department of Pediatrics, University of Nebraska Medical Center USA, 5. Munroe- Meyer Institute, University of Nebraska Medical Center USA)

*ziske maritska maritska1, bintang arroyantri prananjaya2, Nita Parisa Parisa3, Puji Rizki Suryani2, Miranti Dwi Hartati4 (1. Department of Biology Medicine, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia, 2. Department of Psychiatry, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia , 3. Department of Pharmacology, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia, 4. Department of Pharmacology, Faculty of Medicine, Universitas Muhammadiyah Palembang, Palembang, Indonesia)

*Keiichi Shigetome1, Kentaro Oniki1, Keiji Takata2, Yuki Tateyama3, Hiroki Yasuda4, Miu Yokota2, Sae Yamauchi5, Norio Yasui-Furukori6, Kazunori D Yamada7, Junji Saruwatari1 (1. Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan, 2. Division of Pharmacy, Sakurajyuji Hospital, Kumamoto, Japan, 3. Division of Nursing, Sakurajyuji Hospital, Kumamoto, Japan, 4. Division of Respiratory Medicine, Sakurajyuji Hospital, Kumamoto, Japan, 5. Division of Nutrition, Sakurajyuji Hospital, Kumamoto, Japan, 6. Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan, 7. Unprecedented-scale Data Analytics Center, Tohoku University, Sendai, Japan)

[CINP2024] Poster Session

Depression 3 - Clinical (2)

Sat. May 25, 2024 4:50 PM - 5:50 PM CINP Poster Session Hall (Lobby Gallery)

*M. Mercedes Perez-Rodriguez1, Kendall Moore1, Rebecca Jessel1, Juliana Camacho-Castro1, Emma Smith1, Bethany Dubois1, Alexandra Mills1, Elianna Kaplowitz1, Erona Ibroci1, Sophie Orm1, Mara Graziani1, Fumiko Dekio1, Rachel Brody1, Yula Ma1, Frederieke Gigase1, Whitney Lieb1, Teresa Janevic1, Veerle Bergink1, Lotje de Witte1, Anna-Sophie Rommel1, Jia Chen1, Corina Lesseur1 (1. Icahn School of Medicine at Mount Sinai)

*Matthew Jee Yun Kang1,2,3, Jasleen Grewal4, Charles Malpas5, Wei-Hsuan Michelle Chiu1,2, Phil Mitchell6, Mal Hopwood2, Dr Dhamidhu Eratne1,2,3, Dennis Velakoulis1,3,2 (1. Neuropsychiatry Centre, Royal Melbourne Hospital, 2. Department of Psychiatry, University of Melbourne, 3. Melbourne Neuropsychiatry Centre, University of Melbourne, 4. Alfred Mental and Addiction Health, Alfred Health, 5. Department of Medicine, Royal Melbourne Hospital, 6. School of Clinical Medicine, University of Melbourne)

*Junji Saruwatari1, Tomoko Egashira1, Keiichi Shigetome1, Tetsu Tomita2, Shoko Tsuchimine3, Kazuya Morita1, Kazuma Iwashita1, Miki Nishimura1, Kentaro Oniki1, Kazutaka Shimoda3, Norio Yasui-Furukori3 (1. Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan, 2. Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, Japan, 3. Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan)

*Federica Colombo1,2, Elena Manfredi3, Veronica Aggio2, Cristina Lorenzi2, Benedetta Vai1,2, Sara Poletti1,2, Francesco Benedetti1,2 (1. Vita-Salute San Raffaele University, Milan, Italy, 2. IRCCS San Raffaele Hospital, Psychiatry and Clinical Psychobiology Unit - Division of Neuroscience, Milan, Italy, 3. Mood Disorders Unit, Scientific Institute IRCCS San Raffaele Hospital, Milan, Italy)

*Kie Nomoto1, Maya Shirakura2, Saeko Ikai-Tani1,3,4, Yuya Mizuno1,5, Hiroyuki Uchida1 (1. Department of Neuropsychiatry, Keio University School of Medicine, 2. Virginia Polytechnic Institute and State University, 3. Faculty of Kinesiology & Physical Education, University of Toronto, 4. Department of Psychiatry, Minami-Hanno Hospital, 5. Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London)

*Kai Zhang1,2,3, Yitan Yao1,2, Qiongyao Yang1,3, Chuanchuan Chen1,3, Yue Wang1,3, Wenhui Wang1,3, Miaomiao Zhang1,3, Yongjie Zhong1,3, Xiaoping Yuan1 (1. Chaohu Hospital of Anhui Medical University, Hefei, China, 2. Anhui Psychiatric Center, Anhui Medical University, Hefei, China, 3. School of Mental Health and Psychological Sciences, Anhui Medical University, Hefei, China)

*Takashi Tsuboi1, Takeo Nakayama2, Junko Horie3, Fumie Tokuda3, Yoshiya Moriguchi4, Tatsuya Hoshino3 (1. Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan., 2. Department of Health Informatics, School of Public Health, Kyoto University, Kyoto, Japan., 3. Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan., 4. Medical Affairs, Lundbeck Japan K.K, Tokyo, Japan.)

*Yasuyuki Matsumoto1, Hitoshi Sakurai1, Yumi Aoki2, Yoshikazu Takaesu3, Isa Okajima4, Hisateru Tachimori5, Masami Murao1, Taku Maruki1, Takashi Tsuboi1, Koichiro Watanabe1 (1. Department of Neuropsychiatry, Kyorin University Faculty of Medicine, Tokyo, Japan, 2. Psychiatric and Mental Health Nursing, Graduate School of Nursing Science, St. Luke’s International University, Tokyo, Japan., 3. Department of Neuropsychiatry, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan., 4. Department of Psychological Counseling, Faculty of Humanities, Tokyo Kasei University, Tokyo, Japan., 5. Endowed Course for Health System Innovation, Keio University School of Medicine, Tokyo, Japan. )

*Jesper Lindahl1,4, Klara Suneson1,5, Gustav Söderberg 1,2, Johanna Tjernberg1,6, Darya Ståhl1, Simon Ventorp1, Filip Ängeby1,4, Karl Lundblad4,7, Owen M Wolkowitz3, Daniel Lindqvist1,6 (1. Unit for Biological and Precision Psychiatry, Department of Clinical Sciences, Lund, Lund University, 2. Department of Gastroenterology and Nutrition, Department of Clinical Sciences Skåne University Hospital, Malmö, Sweden, 3. Department of Psychiatry and Behavioral Sciences and Weill Institute for Neurosciences, University of California, San Francisco, CA, USA, 4. Office for Psychiatry and Habilitation, Psychiatric Clinic Lund, Region Skåne, Lund, Sweden, 5. Office for Psychiatry and Habilitation, Psychiatric Clinic Malmö, Region, Skåne, Malmö, Sweden, 6. Office for Psychiatry and Habilitation, Psychiatry Research Skåne, Region Skåne, Lund, Sweden, 7. Office for Psychiatry, Norra Stockholm Psykiatri, Region Stockholm, Sweden)

*Maximilian Preiss1,2, Kristian Stamenkovich1,2, Benedikt Schimmerl1,2, Reszö Varga1,2, Emilia Wuketich1,2, Clemens Schmidt1,2, Dan Rujescu-Balcu1,2, Markus Dold1,2, Lucie Bartova1,2, Gabriele Fischer1,2, Lukas Pezawas1,2 (1. Department of Psychiatry and Psychotherapy, Clinical Division of General Psychiatry, Medical University of Vienna, Vienna, Austria, 2. Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria)

[CINP2024] Poster Session

Depression 4 - Preclinical (2)

Sat. May 25, 2024 4:50 PM - 5:50 PM CINP Poster Session Hall (Lobby Gallery)

*Yuki Arakida1, Takashi Asano1, Kazuki Tokoro1, Tomoya Horita1, Naotaka Izuo1, Shin-ichi Muramatsu2,3, Atsumi Nitta1 (1. Department of Pharmaceutical Therapy & Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Japan., 2. Divison of Neurological Gene Therapy, Open Innovation Center, Jichi Medical University, Shimotsuke, Japan., 3. Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.)

*Seiryu Suzuki1, Takashi Asano1, Yuichiro Sugimori1, Naotaka Izuo1, Shin-ichi Muramatsu2,3, Atsumi Nitta1 (1. Department of Pharmaceutical Therapy & Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Japan., 2. Divison of Neurological Gene Therapy, Open Innovation Center, Jichi Medical University, Shimotsuke, Japan., 3. Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.)

*Yuki Honshuku1, Natsuko Hitora-Imamura1, Yurika Miyagami2, Hiroshi Nomura3, Hiroshi Katsuki1, Masabumi Minami2 (1. Dept Chemico-Pharmacol Sci, Grad Sch Pharm Sci, Kumamoto Univ., kumamoto, Japan, 2. Dept Pharmacol, Grad Sch Pharm Sci, Hokkaido Univ, Sapporo, Japan, 3. Dept Cognitive Funct & Pathol, Grad Sch Med Sci, Nagoya City Univ., Nagoya, Japan)

*Takatoshi Sakata1, Akihiro Mouri1,4, Kunisawa Kazuo1, Masaya Hasegawa1, Masao Takemura2, HIdetoshi Matunami5, Kuniaki Saito4,2,3, Toshitaka Nabeshima4,3 (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Sciences, Aichi, Japan., 2. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Aichi, Japan., 3. Laboratory of Health and Medical Science Innovation, Fujita Health University Graduate School of Health Science, Aichi, Japan., 4. Japanese Drug Organization of Appropriate Use and Research (J-DO), Aichi, Japan., 5. Resource Center for Health Science (RECHS), Kyoto, Japan)

*Chi-Wei Lee1, Tzu-Jung Yang1, Ming-Chia Chu1, Hsiang Chi1, Cheng-Ta Li2,3,4,5, Hui-Ching Lin1,2 (1. NaDepartment and Institute of Physiology, Collage of Medicine, National Yang Ming Chiao Tung University, 2. Brain Research Center, National Yang Ming Chiao Tung University, 3. Dpartment of Psychiatry, Taipei Veterans General Hospital, 4. Institute of Brain Science, National Yang-Ming University, 5. Division of Psychiatry, Faculty of Medicine, National Yang-Ming University)

*Moeka Ogawa1, Kazuo Kunisawa1, Aika Kosuge1, Hiroyuki Tezuka2, Toshitaka Nabeshima3,4, Akihiro Mouri1,4 (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Sciences, Aichi, Japan, 2. Department of Cellular Function Analysis, Research Promotion and Support Headquarters, Fujita Health University, Aichi, Japan, 3. Laboratory of Health and Medical Science Innovation, Fujita Health University Graduate School of Health Science, Aichi, Japan, 4. Japanese Drug Organization of Appropriate Use and Research (J-DO), Aichi, Japan)

Zhenlong Li1, Hsien-Yu Peng2, Chau-Shoun Lee2,3, Tzer-Bin Lin4, Ming-Chun Hsieh2, Cheng-Yuan Lai5, Han-Fang Wu6, Lih-Chyang Chen2, Mei-Ci Chen7, *Dylan Chou2 (1. School of Basic Medical Sciences, Zhuhai Campus of Zunyi Medical University, Zhuhai, Guangdong, China, 2. Department of Medicine, MacKay Medical College, New Taipei, Taiwan, 3. Department of Psychiatry, MacKay Memorial Hospital, Taipei, Taiwan, 4. Department of Physiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, 5. Institute of Biomedical Sciences, MacKay Medical College, New Taipei, Taiwan, 6. Department of Optometry, MacKay Medical College, New Taipei, Taiwan, 7. Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taiwan)

[CINP2024] Poster Session

Dementia 1 - Clinical

Sat. May 25, 2024 4:50 PM - 5:50 PM CINP Poster Session Hall (Lobby Gallery)

*Manabu Kubota1,2, Hironobu Endo2, Keisuke Takahata2,3, Kenji Tagai2,4, Hisaomi Suzuki2,5, Mitsumoto Onaya5, Yasunori Sano2,3, Yasuharu Yamamoto2,3, Shin Kurose2,3, Kiwamu Matsuoka2,6, Chie Seki2, Hitoshi Shinotoh2, Kazunori Kawamura2, Ming-Rong Zhang2, Yuhei Takado2, Hitoshi Shimada2,7, Makoto Higuchi2 (1. Graduate School of Medicine, Kyoto University, 2. National Institutes for Quantum Science and Technology, 3. Keio University School of Medicine, 4. Jikei University Graduate School of Medicine, 5. Shimofusa Psychiatric Center, 6. Nara Medical University, 7. Brain Research Institute, Niigata University)

*Che-Sheng Chu1, Shu-Li Cheng2, Ya-Mei Bai2, Tung-Ping Su3, Shih-Jen Tsai2, Tzeng-Ji Chen4, Fu-Chi Yang5, Mu-Hong Chen2, Chih-Sung Liang6 (1. Department of Psychiatry, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, 2. Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan, 3. Department of Psychiatry, Cheng Hsin General Hospital, Taipei, Taiwan, 4. Department of Family Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, 5. Department of Neurology, Tri-Service General Hospital, Taipei, Taiwan, 6. Department of Psychiatry, Beitou Branch, Tri-Service General Hospital, Taipei, Taiwan)

[CINP2024] Poster Session

Translational - Others

Sat. May 25, 2024 4:50 PM - 5:50 PM CINP Poster Session Hall (Lobby Gallery)

*Zachary Aaron Kaminsky1,2,3, Liisa Hantsoo2, Jennifer L. Payne4 (1. University of Ottawa Institute of Mental Health Research, 2. Department of Psychiatry & Behavioral Sciences, The Johns Hopkins University School of Medicine , 3. Department of Cellular and Molecular Medicine, The University of Ottawa, 4. Department of Psychiatry and Neurobehavioral Sciences, University of Virginia)

*Taisuke Yatomi Yatomi1, Dardo Tomasi2, Sakiko Tsugawa1, Hideaki Tani1, Teruki Koizumi3, Nobuhiro Nagai1, Shinichiro Nakajima1, Yohei Ohtani1, Kie Nomoto-Takahashi1, Waki Nakajima4, Mai Hatano4, Hiroyuki Uchida1, Takuya Takahashi4 (1. Department of Neuropsychiatry, Keio University School of Medicine, 2. National Institute on Alcohol Abuse and Alcoholism, 3. Centre for Addiction and Mental Health, University of Toronto, 4. Department of Physiology, Yokohama City University of Graduate School of Medicine)

*Kazuo Kunisawa1, Yumika Sugawara1, Kohei Yoshidomi1, Yuki Kon1, Kuniaki Saito2,3,4, Toshitaka Nabeshima3,4, Akihiro Mouri1,4 (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Sciences, Aichi, Japan., 2. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Aichi, Japan., 3. Laboratory of Health and Medical Science Innovation, Fujita Health University Graduate School of Health Science, Aichi, Japan., 4. Japanese Drug Organization of Appropriate Use and Research (J-DO), Aichi, Japan.)

[CINP2024] Poster Session

Post-Traumatic Stress Disorders

Sat. May 25, 2024 4:50 PM - 5:50 PM CINP Poster Session Hall (Lobby Gallery)

*Chaeyeon Yang1, Aeran Kwon2, Bori Jung1, Seung-Hwan Lee1,3 (1. Clinical Emotion and Cognition Research Laboratory, Department of Psychiatry, Inje University, 2. Department of Social Welfare and Counseling, Chodang University, 3. Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine)

*Shintaro Ogawa1,2, Hiroaki Hori1,2, Madoka Niwa1, Mariko Itoh1,3, Mingming Lin1,4, Fuyuko Yoshida1,2, Keiko Ino1,5, Hitomi Kawanishi1,6,7, Megumi Narita1, Wakako Nakano1, Risa Imai1,5,8, Mie Matsui9, Toshiko Kamo1,10, Hiroshi Kunugi2,11, Yoshiharu Kim1 (1. Department of Behavioral Medicine, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan, 2. Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan, 3. Center for Environmental and Health Sciences, Hokkaido University, Sapporo, Hokkaido, Japan, 4. Laboratory for Imagination and Executive Functions, RIKEN Center for Brain Science, Wako, Saitama, Japan, 5. Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan, 6. Department of Advanced Neuroimaging, Integrative Brain Imaging Center, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan, 7. Department of Behavioral Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan, 8. Risa Irinaka Mental Clinic, Nagoya, Aichi, Japan, 9. Department of Clinical Cognitive Neuroscience, Institute of Liberal Arts and Science, Kanazawa University, Kanazawa, Ishikawa, Japan, 10. Wakamatsu-cho Mental and Skin Clinic, Shinjuku, Tokyo, Japan, 11. Department of Psychiatry, Teikyo University School of Medicine, Itabashi, Tokyo, Japan)

*yuanyuan xu1, Zhenlong Li2, Chau-Shoun Lee3,4, Hsien-Yu Peng3, Tzer-Bin Lin5,6,7, Ming-Chun Hsieh3, Cheng-Yuan Lai8, Dylan Chou9,3 (1. Department of Pharmacology, Zhuhai Campus of Zunyi Medical University , 2. School of Basic Medical Sciences, Zhuhai Campus of Zunyi Medical University, 3. Department of Medicine, MacKay Medical College, 4. Department of Psychiatry, MacKay Memorial Hospital, 5. Institute of New Drug Development, College of Medicine, China Medical University, 6. Cell Physiology and Molecular Image Research Center, Wan Fang Hospital, Taipei Medical University, 7. Department of Physiology, School of Medicine, College of Medicine, Taipei Medical University, 8. Institute of Biomedical Sciences, MacKay Medical College, 9. Department of Physiology, Zhuhai Campus of Zunyi Medical University)

*Shao Han Chang1,2,3,4, Chen Yi Lin1,5, Yao Ming Chang1, Huan Yuan Chen2, Fu Zen Shaw3, Bai Chuang Shyu1 (1. Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, 2. Inflammation Core Facility, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, 3. Department of Psychology, National Cheng Kung University, Tainan, Taiwan, 4. Taiwan International Graduate Program in Interdisciplinary Neuroscience, National Cheng Kung University and Academia Sinica, Taipei, Taiwan, 5. Department of Agricultural Chemistry, National Taiwan University, Taipei, Taiwan)

[CINP2024] Poster Session

Schizophrenia 3 - Clinical (2)

Sat. May 25, 2024 4:50 PM - 5:50 PM CINP Poster Session Hall (Lobby Gallery)

*Yuki Yamamoto1, Genichi Sugihara1, Masaaki Shimizu1, Takahiko Kawashima2, Ayumu Yamashita3,6, Yujiro Yoshihara2, Junichiro Yoshimoto3,8, Jun Miyata2,4, Toshiya Murai2, Mitsuo Kawato3,7, Ming-Chyi Huang9,10, Hidehiko Takahashi1,5 (1. Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan, 2. Department of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 3. Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institutes International (ATR), Kyoto, Japan, 4. Department of Psychiatry, Aichi Medical University, Aichi, Japan, 5. Center for Brain Integration Research, Tokyo Medical and Dental University, Tokyo, Japan, 6. Graduate School of Information Science and Technology, The University of Tokyo, Tokyo, Japan, 7. XNef Incorporation, Kyoto, Japan, 8. Department of Biomedical Data Science, School of Medicine, Fujita Health University, Aichi, Japan, 9. Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan, 10. Department of Psychiatry, School of Medicine, Taipei Medical University, Taipei, Taiwan)

*Pin-Yen Lu1, Yu-Lien Huang6, Kao-Chin Chen2, Po-See Chen2,3,4, Yen-Kuang Yang2,3,5, Huai-Hsuan Tseng2,3 (1. Ju Shan Hospital, Taoyuan, Taiwan, 2. Department of Psychiatry, National Cheng Kung University Hospital, Tainan, Taiwan, 3. Institute of Behavioral Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 4. Department of Psychiatry, National Cheng Kung University Hospital Dou-Liou Branch, Yunlin, Taiwan, 5. Department of Psychiatry, Tainan Hospital, Ministry of Health and Welfare, Tainan, Taiwan, 6. Department of Psychology, Fo Guang University, Yilan, Taiwan)

*Ryosuke Tarumi1,2, Shiori Honda1, Takahide Etani3,4, Saki Homma3, Yuka Kaneko5, Karin Matsushita1, Sotarou Moriyama1, Yui Tobari1, Fumihiko Ueno1,6, Guillermo Horga7, Clifford Cassidy8, Sakiko Tsugawa1, Hiroyuki Uchida1,6, Ariel GraffGuerrero6, Yoshihiro Noda1,6, Shinichiro Nakajima1,6 (1. Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan, 2. Seikei-Kai Komagino Hospital, Japan, 3. Graduate School of Media and Governance, Keio University, Kanagawa, Japan, 4. School of Medicine, College of Medical, Pharmaceutical, and Health, Kanazawa University, Kanazawa, Japan, 5. Faculty of Policy Manegement, Keio University, Kanagawa, Japan, 6. Department of Psychiatry, University of Toronto, Toronto, ON, Canada, 7. Department of Psychiatry, Columbia University, New York, NY, US, 8. Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada)

*Daichi Sone1,2, Alexandra L Young3, Shunichiro Shinagawa1, Sakiko Tsugawa4, Yusuke Iwata4, Ryosuke Tarumi4, Kamiyu Ogyu4, Shiori Honda4, Ryo Ochi4, Karin Matsushita4, Fumihiko Ueno4, Nobuaki Hondo4, Akihiro Koreki4, Edgardo Torres-Carmona5, Wanna Mar5, Nathan Chan5, Teruki Koizumi4, Hideo Kato4, Keisuke Kusudo4, Vincenzo de Luca5, Philip Gerretsen5, Gary Remington5, Mitsumoto Onaya4, Yoshihiro Noda4, Hiroyuki Uchida4, Masaru Mimura4, Masahiro Shigeta1, Ariel Graff-Guerrero5, Shinichiro Nakajima4 (1. Jikei University School of Medicine, 2. UCL Queen Square Institute of Neurology, 3. KIng's College London, 4. Keio University School of Medicine, 5. University of Toronto)

*Yuka Yasuda1, Satsuki Ito1, Junya Matsumoto1, Naohiro Okada1, Masaki Fukunaga1, Kiyotaka Nemoto1, Kenichiro Miura1, Naoki Hashimoto1, Kazutaka Ohi1, Tsutomu Takahashi1, Michihiko Koeda1, Hidenaga Yamamori1, Michiko Fujimoto1, Naomi Hasegawa1, Shinsuke Koike1, Motoaki Nakamura1, Go Okada1, Jun Miyata1, Shusuke Numata1, Toshiaki Onitsuka1, Reiji Yoshimura1, Shin Nakagawa1, Yoshiyuki Watanabe1, Norio Ozaki1, Ryota Hashimoto1 (1. National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan)

*Tzuhan Tseng1, Wei-Fen Ma2,3, Hsien-Yuan Lane4,5,6,7, Cheng-Hao Tu8 (1. School of Chinese medicine, China medical university, Taichung, Taiwan, 2. Department of Nursing, China Medical University Hospital, Taichung, Taiwan, 3. School of Nursing, China Medical University Hospital, Taichung, Taiwan, 4. The Brain Disease Research Center, China Medical University Hospital, Taichung, Taiwan, 5. Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, 6. Department of Psychiatry, China Medical University Hospital, Taichung, Taiwan, 7. Department of Psychology, College of Medical and Health Sciences, Asia University, Taichung, Taiwan, 8. Graduate Institute of Acupuncture Science, China Medical University, Taichung, Taiwan)

*Edgardo Torres-Carmona1, Fumihiko Ueno1, Yusuke Iwata2, Shinichiro Nakajima2, Jianmeng Song2, Wanna Mar1, Ali Abdolizadeh1, Sri Mahavir Agarwal1, Vincenzo de Luca1, Gary Remington1, Philip Gerretsen1, Ariel Graff-Guerrero1 (1. Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada, 2. Department of Neuropsychiatry, Keio University, Minato, Tokyo, Japan, MD)

*Saeko Ikai-Tani1,2,3, Saki Kamiyma2,4, Hideaki Tani2, Hiroyuki Uchida2 (1. Department of Psychiatry, Minami-Hanno Hospital, Saitama, Japan, 2. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 3. Faculty of Kinesiology & Physical Education, University of Toronto, Toronto, ON, Canada, 4. Department of Psychiatry, Tokyo Dental College Ichikawa General Hospital, Chiba, Japan)

*Naomi Hasegawa1, Yuka Yasuda2,1, Norio Yasui-Furukori3, Hikaru Hori4, Kayo Ichihashi5, Yoshikazu Takaesu6, Hitoshi Iida4, Hiroyuki Muraoka7, Fumitoshi Kodaka8, Junya Matsumoto1, Kenichiro Miura1, Ken Inada7, Koichiro Watanabe9, Ryota Hashimoto1 (1. Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan, 2. Life Grow Brilliant Mental Clinic, Medical Corporation Foster, Osaka, Japan, 3. Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan, 4. Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan, 5. Department of Neuropsychiatry, University of Tokyo Hospital, Tokyo, Japan, 6. Department of Neuropsychiatry, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan, 7. Department of Psychiatry, Kitasato University, School of Medicine, Kanagawa, Japan, 8. Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan, 9. Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan)

*Maite Arribas1, Dominic Oliver1,2,3,4, Rashmi Patel5, Daisy Kornblum6, Hitesh Shetty6, Stefano Damiani7, Kamil Krakowski1,7, Umberto Provenzani7, Daniel Stahl6,9, Nikolaos Koutsouleris8,10,11, Philip McGuire2,3,4, Paolo Fusar-Poli1,6,7,12 (1. Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK, 2. Department of Psychiatry, University of Oxford, Oxford, UK, 3. NIHR Oxford Health Biomedical Research Centre, Oxford, UK, 4. OPEN Early Detection Service, Oxford Health NHS Foundation Trust, Oxford, UK, 5. Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK, 6. NIHR Maudsley Biomedical Research Centre, London, UK, 7. Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy, 8. Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK, 9. Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, London, UK, 10. Department of Psychiatry and Psychotherapy, Ludwig-Maximilian University, Munich, Germany, 11. Max-Planck Institute of Psychiatry, Munich, Germany, 12. OASIS Service, South London and Maudsley NHS Foundation Trust, London, UK)

*Alessandro Serretti1, Roberto Rodríguez-Jiménez2,3, Veronica Romero-Ferreiro4, Aggie Nuñez-Doyle2, Chiara Fabbri1, Giuseppe Fanelli1, Mauro Scala1,2 (1. Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy, 2. Psychiatry, Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain, 3. CIBERSAM, Madrid, Spain, 4. Universidad Europea de Madrid (UEM), Madrid, Spain)

*Alessandro Serretti1, Roberto Rodríguez-Jiménez2,3, Veronica Romero-Ferreiro4, Aggie Nuñez-Doyle2, Chiara Fabbri1, Giuseppe Fanelli1, Mauro Scala1,2 (1. Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy, 2. Psychiatry, Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain, 3. CIBERSAM, Madrid, Spain, 4. Universidad Europea de Madrid (UEM), Madrid, Spain)

*Alessandro Serretti1, Roberto Rodríguez-Jiménez2,3, Veronica Romero-Ferreiro4, Aggie Nuñez-Doyle2, Chiara Fabbri1, Giuseppe Fanelli1, Mauro Scala1,2 (1. Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy, 2. Psychiatry, Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain, 3. CIBERSAM, Madrid, Spain, 4. Universidad Europea de Madrid (UEM), Madrid, Spain)

*Yoshihiro Matsumoto1,2, Nobutaka Ayani1,3, Nozomu Oya1, Riki Kitaoka1, Anri Watanabe1, Hiroko Yoshii4, Yuichi Kitaura6,5, Shinichiro Inoue7, Jin Narumoto1 (1. Kyoto Prefectural University of Medicine, 2. Kyoto Prefectural Mental Health Center, 3. Maizuru Medical Center, 4. Kansai Medical University Medical Center, 5. Kansai Medical University, 6. Matsushita Memorial Hospital, 7. Nimi University)

[CINP2024] Poster Session

Schizophrenia 4 - Translational

Sat. May 25, 2024 4:50 PM - 5:50 PM CINP Poster Session Hall (Lobby Gallery)

Kyungtaek Park 3, Nuree Kang1, Seong-Hoo Huh4, Sungho Won3,5, *Se Hyun Kim1,2 (1. Department of Psychiatry, Seoul National University Hospital, Seoul, Republic of Korea, 2. Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea, 3. Institute of Health and Environment, Seoul National University, Seoul, Republic of Korea, 4. Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea, 5. Department of Public Health Science, Seoul National University, Seoul, Republic of Korea)

*Yuya Mizuno1,2,3, Tiago Reis Marques1,4,5, Julia Schubert6, Mattia Veronese6,7, Federico Turkheimer6, Oliver D. Howes1,2,4,5 (1. Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK, 2. South London & Maudsley NHS Foundation Trust, London, UK, 3. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 4. Psychiatric Imaging Group, MRC London Institute of Medical Sciences, Imperial College London, London, UK, 5. Psychiatric Imaging Group, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK, 6. Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK, 7. Department of Information Engineering, University of Padua, Padua, Italy)

*Fumihiko Ueno1,2,3, Yusuke Iwata9, Shiori Honda3, Guillermo Horga4,5, Clifford M Cassidy6, Edgardo Torres-Carmona1,7, Jianmeng Song1,7, Vincenzo de Luca2,7,8, Sakiko Tsugawa3, Yoshihiro Noda3, Mahavir Agarwal2,7,8, Philip Gerretsen1,2,7,8, Shinichiro Nakajima3, Ariel Graff-Guerrero1,2,7,8 (1. Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada, 2. Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada, 3. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 4. Department of Psychiatry, Columbia University, New York, NY, USA, 5. Division of Translational Imaging, New York State Psychiatric Institute, New York, NY, USA, 6. The Royal’s Institute of Mental Health Research Affiliated with the University of Ottawa, Ottawa, Ontario, Canada, 7. Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada, 8. Campbell Family Mental Health Research Institute, CAMH, Toronto, Ontario, Canada, 9. Department of Neuropsychiatry, University of Yamanashi, Faculty of Medicine, Yamanashi, Japan)

*Gerardo Mendez Victoriano1,2,3, Yunting Zhu1, Frank Middleton1, Maree J. Webster4, Cynthia S. Weickert1,2,3 (1. Department of Neuroscience and Physiology, Upstate Medical University, Syracuse, NY, USA, 2. Neuroscience Research Australia, Sydney, NSW, Australia, 3. School of Clinical Medicine, Faculty of Medicine & Health, University of New South Wales, Sydney, NSW 2052, Australia, 4. Laboratory of Brain Research, Stanley Medical Research Institute, 9800 Medical Center Drive, Rockville, MD, USA)

[CINP2024] Poster Session

Eating Disorders

Sat. May 25, 2024 4:50 PM - 5:50 PM CINP Poster Session Hall (Lobby Gallery)

[CINP2024] Poster Session

Pain

Sat. May 25, 2024 4:50 PM - 5:50 PM CINP Poster Session Hall (Lobby Gallery)

*Kaori Ohshima1,2, Miki Nonaka2, Yui Kuroda2,3, Kanako Miyano2, Hiroshi Takayanagi1, Yasuhito Uezono2,3 (1. Pathology, Immunology and Microbiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 2. Department of Pain Control Research, The Jikei University School of Medicine, Tokyo, Japan, 3. Department of Anesthesiology and Pain Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan)

*Tomofumi Otsuki1,2, Joao Pedro Junqueira1, Jumpei Matsumoto1,4, Tsuyoshi Setogawa 1,4, Daisuke Uta3, Hiroshi Nishimaru1,4 (1. System Emotional Science, Faculty of Medicine, University of Toyama, Japan, 2. Graduate school of Innovative Life Science, University of Toyama, Japan, 3. Department of Applied Pharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Japan, 4. Research Center for Idling Brain Science (RCIBS), University of Toyama, Japan)

*Keiko Yamada1,2, Sakiko Yamaguchi3,4, Naoki Mizunuma5,6,7, Takashi Takeda8 (1. Juntendo University Graduate School of Medicine, Tokyo, Japan, 2. Department of Anesthesiology and Pain Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan, 3. School of Physical and Occupational Therapy, Faculty of Medicine and Health Sciences, McGill University, 4. Knowledge Mobilization Program, CHILD-BRIGHT Network, 5. Department of Legal Medicine, Toho University Graduate School of Medicine, Tokyo, Japan, 6. Tokyo Kagurazaka Law office, Tokyo Japan, 7. Division of Forensic Medicine, Department of Social Medicine, Faculty of Medicine, Tottori University, Yonago, Tottori, Japan, 8. Division of Women’s Health, Research Institute of Traditional Asian Medicine, Kindai University, Osaka-sayama, Osaka)

*Yuna Kang1,2, Seii Ohka1, Daisuke Nishizawa1, Junko Hasegawa1, Kyoko Nakayama1, Yuko Ebata1, Takeshi Terui3, Kunihiko Ishitani3, Ryozo Morino4, Miyuki Yokota5,6, Kyotaro Koshika2, Tatsuya Ichinohe2, Kazutaka Ikeda1 (1. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science. Tokyo, Japan., 2. Department of Anesthesiology, Tokyo Dental College. Tokyo, Japan., 3. Division of Internal Medicine, Department of Medicine, Higashi-Sapporo Hospital, Sapporo, Japan., 4. Division of Anesthesiology, Koujinkai Daiichi Hospital, Tokyo, Japan., 5. Department of Anesthesiology, Cancer Institute Hospital, Tokyo, Japan., 6. Department of Anesthesiology, East Hokkaido Hospital, Kushiro, Japan.)

*Ekachaeryanti Zain1,2, Atsunori Sugimoto3,4, Jun Egawa5, Toshiyuki Someya1 (1. Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan, 2. Department of Psychiatry, Faculty of Medicine, Mulawarman University, Samarinda, Indonesia, 3. Department of Community Psychiatric Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan, 4. Department of Psychiatry, Niigata Psychiatric Center, Nagaoka, Japan, 5. Department of Psychiatry, Niigata University Medical and Dental Hospital, Niigata, Japan)

[CINP2024] Poster Session

Sleep Disorders

Sat. May 25, 2024 4:50 PM - 5:50 PM CINP Poster Session Hall (Lobby Gallery)

*Seiko Miyata1, Ippei Okada1, Kunihiro Iwamoto1, Akihiro Fujimoto2, Yuki Kogo2, Manabu Amano3, Nao Matsuyama3, Norio Ozaki4, Masashi Ikeda1 (1. Department of Psychiatry, Nagoya University, Graduate School of Medicine, Nagoya, Japan, 2. Eisai Co., Ltd., Tokyo, Japan, 3. Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan, 4. Pathophysiology of Mental Disorders, Nagoya University, Graduate School of Medicine, Nagoya, Japan)

*Motohiro Ozone1, Susumu Hirota2, Yu Ariyoshi3, Kenichi Hayashida4, Azusa Ikegami5, Mitsunari Habukawa1, Hayato Ohshima1, Daisuke Harada6, Hiroshi Hiejima1, Nozomu Kotorii7, Kenta Murotani8, Takehiro Taninaga9, Naohisa Uchimura1 (1. Kurume University School of Medicine, Fukuoka, Japan, 2. Hirota Clinic, Fukuoka, Japan, 3. Yu Ariyoshi Sleep Clinic, Fukuoka, Japan, 4. Sleep Support Clinic, Tokyo, Japan, 5. Kuwamizu Hospital, Kumamoto, Japan, 6. Sleep & Stress Clinic, Tokyo, Japan, 7. Kotorii Isahaya Hospital, Nagasaki, Japan, 8. Kurume University, Fukuoka, Japan, 9. Eisai Co., Ltd, Tokyo, Japan)

*Kazumaro Okino1,2, Hirohisa Suzuki2,3, Hiroi Tomioka, Atsuko Inamoto1,2 (1. Mental care center, Showa University Northern Yokohama Hospital, 2. Department of Neuropsychiatry, Showa University School of Medicine, 3. Neuropsychiatry, Showa University Karasuyama Hospital)

*HuangChi Wang1, WenYu Hsu2, TingGang Chang3, ChengChen Chang1, SiYu Chu4 (1. Department of Psychiatry, Chung Shan Medical University Hospital, Taichung, Taiwan, 2. Department of Psychiatry, Changhua Christian Hospital , Changhua, Taiwan, 3. Department of Psychiatry, Taichung Veterans General Hospital, Taichung, Taiwan, 4. Department of Medical Education, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan)

*Chul-Hyun Cho1,2, Yoonseo Jeon1, Jingyeong Jeong1, Hyungju Kim3, Taesu Cheong3, Ji Won Yeom1, Heon-Jeong Lee1 (1. Department of Psychiatry, Korea University College of Medicine, Seoul, Korea, 2. Department of Biomedical Informatics, Korea University College of Medicine, Seoul, Korea, 3. Department of Industrial Management Engineering, Korea University Graduate School, Seoul, Korea)

*HSIAOHSIEH WANG1, Chihiro Nozaki2, Shigenobu Shibata3, Toru Asahi4 (1. Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan, 2. Global Science and Engineering Center, Waseda University, Tokyo, Japan, 3. Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan, 4. Research Organization for Nano & Life Innovation, Waseda University, Tokyo, Japan)

*Masayuki Miyazaki1,2, Hiroko Yagihara1, Hiromi Fujita3, Hodaka Yamakado4, Keiji Wada3, Eiko N Minakawa1 (1. Department of Neurophysiology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan, 2. Department of NCNP Brain Physiology and Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan, 3. Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan, 4. Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan)

[CINP2024] Poster Session

Suicide

Sat. May 25, 2024 4:50 PM - 5:50 PM CINP Poster Session Hall (Lobby Gallery)

*Sidney Yap1, Manroop Bal1, Mina Youakim1, Ashraf Aborawi1, Genna Di Pinto1, Krystle Samways1, Amy Beck2, Katherine Bright2, Suzette Bremault-Phillips2,3, Andrew Greenshaw1, Olga Winkler1, Lisa Burback1 (1. Department of Psychiatry, University of Alberta, Edmonton, Canada , 2. Heroes in Mind, Advocacy and Research Consortium, University of Alberta, Edmonton, Canada, 3. Department of Occupational Therapy, University of Alberta, Edmonton, Canada )

*Sunghyeon Park3, Ji-won Chun3, Dai Jin Kim1,2 (1. Department of Biomedicine & Health Sciences, The Catholic University of Korea College of Medicine, Seoul, KOREA, 2. Department of Psychiatry, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, KOREA, 3. Department of Medical Informatics, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea)

[CINP2024] Poster Session

Autism

Sat. May 25, 2024 4:50 PM - 5:50 PM CINP Poster Session Hall (Lobby Gallery)

*Benchalak Maneeton1, Prapinpatch Maneeton2, Yanisa Winichaikul3, Suttipong Kawilapat1, Nongluck Kienngam4, Narong Maneeton1 (1. Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand, 2. Chiang Mai University Demonstration School, Faculty of Education, Chiang Mai University, Chiang Mai 50200, Thailand, 3. Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand., 4. Department of Education Psychology and Guidance Program, Faculty of Education Chiang Mai University, Chiang Mai 50200, Thailand)

*Tomoyasu Wakuda1, Seico Benner1,2, Yukari Uemura3, Masaki Kojima4, Yosuke Kameno1,5, Hitoshi Kuwabara1,5, Hidenori Yamasue1,5, +32 co-authors6 (1. Department of Psychiatry, Hamamatsu University School of Medicine, Shizuoka, Japan, 2. Center for Health and Environmental Risk Research, National Institute for Environmental Studies, Ibaraki, Japan, 3. Biostatistics Section, Department of Data Science, Center for Clinical Science, National Center for Global Health and Medicine, Tokyo, Japan, 4. Department of Child Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 5. Department of Child Development, United Graduate School of Child Development at Hamamatsu, Shizuoka, Japan, 6. University Hospitals in Japan)

*Kohei Kitagawa1, Tomoya Takemoto1, Kaoru Seiriki1, Atsushi Kasai1,2, Hitoshi Hashimoto1,3,4,5,6, Takanobu Nakazawa7 (1. Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 2. Systems Brain Science Project, Drug Innovation Center, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 3. United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Japan, 4. Division of Bioscience, Institute for Datability Science, Osaka University, Osaka, Japan, 5. Transdimensional Life Imaging Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka, Japan, 6. Department of Molecular Pharmaceutical Science, Graduate School of Medicine, Osaka University, Osaka, Japan, 7. Department of Bioscience, Faculty of Bioscience, Tokyo University of Agriculture, Tokyo, Japan)

*Yoko Nawata1, Tsuyoshi Nishioku1, Taku Yamaguchi2 (1. Department of Pharmacology, Faculty of Pharmaceutical Science, Nagasaki International University, Nagasaki, Japan, 2. Department of Pharmacotherapeutics and Neuropsychopharmacology, Faculty of Pharmaceutical Science, Nagasaki International University, Nagasaki, Japan)

*Yi-Ting Pan1, Chi-Chun Wu3, Ming-Chai Chu3, Chen-Jiun Yeh1, Dishary Sharmin4, James Cook4, Hui-Ching Lin3, Lih-Chu Chiou1,2 (1. Graduate Institute of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan, 2. Graduate Institute of Brain and Mind Sciences, College of Medicine, National Taiwan University, Taipei, Taiwan, 3. Department and Institute of Physiology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, 4. Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI, USA)

*Hiroko Kotajima1, Atsushi Sato1, Shinya Kasai2, Yoko Hagino1, Miho Tanaka3, Yukio Takamatsu4, Yoshimasa Nishito4, Shigeo Uchino5, Kazutaka Ikeda1 (1. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Japan, 2. Department of Biotechnology, Center for Advanced Assisted Reproductive Technologies, University of Yamanashi, Japan, 3. Department of Psychiatry, The University of Tokyo Hospital, Japan, 4. Center for Basic Technology Research, Tokyo Metropolitan Institute of Medical Science, Japan, 5. Department of Biosciences, School of Science and Engineering, Teikyo University, Japan)

Chia-Wei Liou1,2, Sin-Jhong Cheng3, Tzu-Hsuan Yao1,2, Tzu-Ting Lai1,2, Yu-Hsuan Tsai1,2, *Wei-Li Wu1,2 (1. Department of Physiology, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 2. Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 3. Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan)

*Tobias Patrick Whelan1,2, Lucas G.S. Franca 1,3, Mihail Dimitrov 1, Naoise Mulcrone 1, Nicolaas A. Puts1,4, Eileen Daly 1, Declan G.M. Murphy1,4, Grainne M. McAlonan1,4 (1. Dept. of Forensic & Neurodevelopmental Sciences, King's College London, , 2. COMPASS Pathfinder Ltd. , 3. Dept. of Computer & Information Sciences, Northumbria University , 4. NIHR-Maudsley Biomedical Research Centre at Maudsley NHS Foundation Trust & King's College London )

*Shotaro Kawano1, Toshihiko Kuriu2, Sayaka Katayama1, Manaka Otomo1, Daiki Miura1, Hotaka Fukushima1, Kazuhiro Takuma3, Fumihito Ono4, Hitoshi Hashimoto5,6,7,8,9,10, Ryota Hashimoto6, Takanobu Nakazawa1,6 (1. Department of Bioscience, Graduate School of Life Sciences, Tokyo University of Agriculture, Tokyo, Japan, 2. Osaka Medical and Pharmaceutical University, Research and Development Center, Osaka, Japan, 3. Department of Pharmacology, Graduate School of Dentistry, Osaka University, Osaka, Japan, 4. Department of Physiology, Division of Life Science, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan, 5. Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 6. Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan, 7. United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Japan, 8. Division of Bioscience, Institute for Datability Science, Osaka University, Osaka, Japan, 9. Transdimensional Life Imaging Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka, Japan, 10. Department of Molecular Pharmaceutical Science, Graduate School of Medicine, Osaka University, Osaka, Japan)

[CINP2024] Poster Session

Clinical - Others (2)

Sat. May 25, 2024 4:50 PM - 5:50 PM CINP Poster Session Hall (Lobby Gallery)

*Mariko Tsukiji1, Shinichi Hikasa2, Masashi Ishihara3, Yusuke Kunimoto4, Kazuko Nobori5, Takeshi Kimura6, Kenta Onishi7, Yuuki Yamamoto8, Kyohei Haruta9, Yohei Kasiwabara10, Kenji Fujii11, Shingo Yamazaki1, Tomihisa Niitsu12, Hidetoshi Igari13, Itsuko Ishii1 (1. Division of Pharmacy, Chiba University Hospital, 2. Department of Pharmacy, Hyogo Medical University Hospital, 3. Department of Pharmacy, Gifu University Hospital, 4. Department of Hospital Pharmacy, Sapporo Medical University Hospital, 5. Department of Pharmacy, Kobe City Medical Center General Hospital, 6. Department of Pharmacy, Kobe University Hospital, 7. Division of Pharmacy, Wakayama Medical University Hospital, 8. Division of Pharmacy, Himeji Medical Center, 9. Department of Pharmacy, Nara Medical University Hospital, 10. Division of Pharmacy, Japanese Red Cross Kyoto Daiichi Hospital, 11. Division of Pharmaceutical Services, Hiroshima University Hospital, 12. Department of Psychiatry, Chiba University Graduate School of Medicine, 13. Department of Infection Diseases, Chiba University Hospital)

*Naohiro Arai1,2, Yuki Sugiura3, Shinichiro Nakajima1, Masataka Wada1, Sotaro Moriyama1, Yu Mimura1, Kousuke Takayama1, Kanta Niinomi1, Shuken Boku2, Masaru Mimura1, Minoru Takebayashi2, Hiroyuki Uchida1, Yoshihiro Noda1 (1. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 2. Department of Neuropsychiatry, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan, 3. Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan)

*Miyako Nakagawa1, Kosuke Doki1, Mana Obata-Yasuoka2, Hiromi Hamada2, Daisuke Hitaka3, Yayoi Miyazono4, Hidetoshi Takada4, Masato Homma1 (1. Department of Pharmaceutical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan, 2. Department of Obstetrics and Gynecology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan, 3. Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan, 4. Department of Child Health, Institute of Medicine, University of Tsukuba, Tsukuba, Japan)

*Rafael Freire1,2,3, Marcos Fidry3, Clara Faria3, Mariana Cabo3, Ursula Matos3, Ricardo Steffen4, Antonio Nardi3 (1. Department of Psychiatry and Centre for Neuroscience Studies, Queen's University, Kingston, Ontario, Canada, 2. Kingston General Hospital Research Institute, Kingston Health Sciences Centre, Kingston, Canada., 3. Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, 4. Institute of Social Medicine, Rio de Janeiro State University, Rio de Janeiro, Brazil)

[CINP2024] Poster Session

Preclinical - Others (1)

Sat. May 25, 2024 4:50 PM - 5:50 PM CINP Poster Session Hall (Lobby Gallery)

*Henrieta Oravcova1, Daniil Grinchii2, Zuzana Romanova1, Lubica Lacinova2, Eliyahu Dremencov2, Daniela Jezova1 (1. Institute of Experimental Endocrinology, Biomedical research center, Slovak academy of Sciences, 2. Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences)

*Kathleen Frances Vincent1,2, Angel J Cho3,1, Ken Solt1,2 (1. Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA, 2. Department of Anaesthesia, Harvard Medical School, Boston, Massachusetts, USA, 3. Touro College of Osteopathic Medicine, New York, New York, USA)

Kazuki Fujii1,2,3, Yumie Koshidaka2, Mayumi Adachi2, Yuko Yanagibashi2, Mina Matsuo2, Shoko Hongo2, Hirofumi Nishizono4, Ichiro Takasaki5, Nobuyuki Kurosawa6,7, Yasunori Aizawa8,9, *Keizo Takao1,2,3,7 (1. Department of Behavioral Physiology, Faculty of Medicine, University of Toyama, Toyama, Japan, 2. Life Science Research Center, University of Toyama, Toyama, Japan, 3. Research Center for Idling Brain Science, University of Toyama, Toyama, Japan, 4. Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan, 5. Department of Pharmacology, Graduate School of Science and Engineering, University of Toyama, Toyama, Japan, 6. Laboratory of Molecular and Cellular Biology, Department of Life Sciences and Bioengineering, Faculty of Engineering, University of Toyama, Toyama, Japan, 7. Center for Advanced Antibody Drug Development, University of Toyama, Toyama, Japan, 8. Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Yokohama, Japan, 9. Kanagawa Institute of Industrial Science and Technology, Ebina, Japan)

*Sebastian Klug1,2, Murray B. Reed1,2, Chrysoula Vraka3, Godber M Godbersen1,2, Arkadiusz Komorowski1,2, Pia Falb1,2, Lukas Nics3, Tatjana Traub-Weidinger3, Marcus Hacker3, Rupert Lanzenberger1,2, Andreas Hahn1,2 (1. Department of Psychiatry and Psychotherapy, Medical University of Vienna, Austria, 2. Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria, 3. Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Austria)

[CINP2024] Poster Session

Others (1)

Sat. May 25, 2024 4:50 PM - 5:50 PM CINP Poster Session Hall (Lobby Gallery)

*Tzu-Ting Lai1,2, Yu-Hsuan Tsai1,2, Chia-Wei Liou1,2, Ching-Hsiang Fan3, Yu-Tian Hou3, Tzu-Hsuan Yao2, Hsiao-Li Chuang4, Wei-Li Wu1,2 (1. Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, 2. Department of Physiology, College of Medicine, National Cheng Kung University, 3. Department of Biomedical Engineering, College of Engineering, National Cheng Kung University, 4. National Laboratory Animal Center, National Applied Research Laboratories)

*Yue Liu1, Hiroyuki Mizoguchi1,2, Akira Sobue3, Naruhiko Sahara4, Koji Yamanaka3, Kiyofumi Yamada1 (1. Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Japan, 2. Medical Interactive Research and Academia-Industry Collaboration Center, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan, 3. Department of Neuroscience & Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan, 4. Department of Functional Brain Imaging, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan)

*Michaela Krivosova1, Peter Hutka2, Igor Hrtanek2, Igor Ondrejka2, Laura Maggioni3, Matteo Marcatili4, Massimo Clerici4, Juraj Mokry5 (1. Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, Martin, Slovakia, 2. Psychiatric Clinic, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, Martin University Hospital, Martin, Slovakia, 3. Psychiatric Department, ASST Bergamo Ovest, Bergamo, Italy, 4. Department of Mental Health and Addiction, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy, 5. Department of Pharmacology, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, Martin, Slovakia)

*Zhenlong Li1, Yuanyuan Xu2, Rourou Li1, Zhenyu Sheng1, Xueman Liu1, Chau-Shoun Lee3, Hsien-Yu Peng3, Tzer-Bin Lin6, Ming-Chun Hsieh3, Cheng-Yuan Lai4, Han-Fang Wu5, Dylan Chou3 (1. School of Basic Medical Sciences,Zhuhai Campus of Zunyi Medical University,Zhuhai, Guangdong,China, 2. Department of Pharmacology,Zhuhai Campus of Zunyi Medical University,Zhuhai, Guangdong,China, 3. Department of Medicine, MacKay Medical College, New Taipei, Taiwan, 4. Institute of Biomedical Sciences,MacKay Medical College,New Taipei,Taiwan, 5. Department of Optometry, MacKay Medical College, New Taipei, Taiwan, 6. Institute of New Drug Development, College of Medicine, China Medical University, Taichung, Taiwan)

*Cheng-Chen Chang1,2, Chun-Min Chen4, I-Chien Wu3, Agnes C. Hsiung3, Hsing-Yi Chang3 (1. Department of Psychiatry, Chung Shan Medical University Hospital, Taichung, Taiwan, 2. School of Medicine, Chung Shan Medical University, Taichung, Taiwan, 3. Institute of Population Health Sciences, National Health Research Institutes, Maoli, Taiwan, 4. Big Data Center, Changhua Christian Hospital, Changhua, Taiwan)

[CINP2024] Poster Session

Bipolar Disorders (2)

Sun. May 26, 2024 1:30 PM - 2:30 PM CINP Poster Session Hall (Lobby Gallery)

*Ya Mei Bai1,2,3, Mu Hong Chen1,2, Ju-Wei Hsu1,2, Ying-Jay Liou1,2 (1. Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan., 2. Department of Psychiatry, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan., 3. Institute of Brain Science, National Yang Ming Chiao Tung University, Taipei, Taiwan.)

*Yi-Jie Liang1, Chih-Chun Huang2,3, Yun-Hsuan Chang4,5,6,7, Tzu-Yun Wang3, Hsien-Yuan Lane1,8,9 (1. Asia University, 2. Department of Psychiatry, National Cheng Kung University Hospital, 3. Department of Psychiatry, National Cheng Kung University & Hospital, College of Medicine, National Cheng Kung University, 4. Institute of Gerontology, College of Medicine, National Cheng Kung University, 5. Institute of Behavioral Medicine, College of Medicine, National Cheng Kung University, 6. Department of Psychology, National Cheng Kung University, 7. Institute of Genomics and Bioinformatics, National Chung Hsing University, 8. Department of Psychiatry and Brain Disease Research Center, China Medical University Hospital, 9. Graduate Institute of Biomedical Sciences, China Medical University)

*Yu Wei Lin1, Chih Chun Huang2,3, Yun Hsuan Chang4,5,6,7, Chun Yuan Lin8, Tsau Hong Lane8,9 (1. Department of Psychology, Asia University, Taichung, Taiwan, 2. Department of Psychiatry, National Cheng Kung University Hospital, Dou-Liou Branch, Yunlin, Taiwan, 3. Department of Psychiatry, National Cheng Kung University & Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 4. Institute of Gerontology, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 5. Institute of Behavioral Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 6. Department of Psychology, National Cheng Kung University, Tainan, Taiwan, 7. Institute of Genomics and Bioinformatics, National Chung Hsing University, Taichung, Taiwan, 8. Department of Psychiatry, Tsaotun Psychiatric Center, Ministry of Health and Welfare, Nantou, Taiwan, 9. Department of Psychiatry, National Yang Ming Chiao Tung University, Taipei, Taiwan)

*Cheng Che Shen1, Ya-Han Hu2, Ya-Mei Bai3 (1. Department of Psychiatry, Chiayi Branch, Taichung Veterans General Hospital, Chiayi, Taiwan, 2. Department of Information Management, National Central University, Taoyuan City, Taiwan, 3. Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan)

*Tasuku Hashimoto1,2, Hiroki Ishii3,2, Aiko Sato1,2, Mami Tanaka4, Ryota Seki2, Michi Ogawa2, Atsushi Kimura2, Masaomi Iyo2 (1. Department of Psychiatry, International University of Health and Welfare Narita Hospital, Narita, Japan, 2. Department of Psychiatry, Chiba University, Chiba, Japan, 3. Department of Psychiatry, Sodegaura Satsukidai Hospital, Sodegaura, Japan, 4. Department of Psychology, Faculty of Liberal Arts, Teikyo University)

*Ying Tsung Tsai1,2, Yu-Lien Huang3, Tsung-Hua Lu1, Wei Hung Chang1,4, Yen Kuang Yang1,2,5, Po See Chen1,2, Huai-Hsuan Tseng1,2 (1. Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 2. Institute of Behavioral Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 3. Department of Psychology, Chung Shan Medical University, Taichung, Taiwan, 4. Department of Psychiatry, National Cheng Kung University Hospital, Dou-Liou Branch, Yunlin, Taiwan, 5. Department of Psychiatry, Tainan Hospital, Ministry of Health and Welfare, Tainan, Taiwan)

*Hong-li WANG1,2, Ya-zhou LU1,2, Xiao-ning SHI1,2, Ying-ying ZHAO1,2, Wen-wen DUN1,2, Xue-quan ZHU1,2, Ling ZHANG1,2 (1. The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China , 2. Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China)

*Tzu-Yun Wang1, Shao-Ming Wang2,3, Yun-Hsuan Chang4,5,6, Ru-Band Lu1, Hui Hua Chang7,8,9,10 (1. Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 2. Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, 3. Neuroscience and Brain Disease Center, China Medical University, Taichung, Taiwan, 4. Institute of Gerontology, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 5. Institute of Behavioral Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 6. Institute of Genomics and Bioinformatics, College of Life Sciences, National Chung Hsing University, Taichung, Taiwan, 7. Institute of Clinical Pharmacy and Pharmaceutical Sciences College of Medicine, National Cheng Kung University, Tainan, Taiwan, 8. School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 9. Department of Pharmacy, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 10. Department of Pharmacy, National Cheng Kung University Hospital, Dou-Liou Branch, Yunlin, Taiwan)

*Tzu-Yun Wang1, Shao-Ming Wang2,3 (1. Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 2. Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, 3. Neuroscience and Brain Disease Center, China Medical University, Taichung, Taiwan)

*Ahmad Hatim Sulaiman1, Mustafa M. Amin5, Jin Kiat Ang 13, Roger Ho7, Nik Ruzyanei Nik Jaafar14, Chong Guan Ng1, Adhi Wibowo Nurhidayat6, Pongsatorn Paholpak11, Pornjira Pariwatcharakul12, Thitima Sanguanvichaikul10, Eng Khean Ung 8, Natalia Dewi Wardani4, Brian Yeo9, Christoph U. Correll3,2 (1. Department of Psychological Medicine, University of Malaya, Petaling Jaya, Malaysia, 2. Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA , 3. Department of Child and Adolescent Psychiatry, Charité – Universitätsmedizin Berlin, Berlin, Germany, 4. Department of Psychiatry, Diponegoro University, Central Java, Indonesia, 5. Department of Psychiatry, Medical Faculty North Sumatera University, Medan, Indonesia, 6. Department of Psychiatry, Dr. Soeharto Heerdjan Mental Hospital, Jakarta, Indonesia, 7. Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 8. Adam Road Medical Centre, Singapore, Singapore, 9. Mount Elizabeth Medical Centre, Singapore, Singapore, 10. Department of Psychiatry, Somdet Chaopraya Institute of Psychiatry, Bangkok, Thailand , 11. Department of Psychiatry, Khon Kaen University, Khon Kaen, Thailand, 12. Department of Psychiatry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 13. Department of Psychiatry, Hospital Sultan Abdul Aziz Shah, UPM, Serdang, Selangor, Malaysia, 14. Department of Psychiatry, Hospital Canselor Tuanku Muhriz UKM, Kuala Lumpur, Malaysia)

[CINP2024] Poster Session

Dementia 2 - Preclinical and others

Sun. May 26, 2024 1:30 PM - 2:30 PM CINP Poster Session Hall (Lobby Gallery)

*Yicong Liu1, Junjun Ni2 (1. Stomatology Hospital, School of Stomatology, Clinical Research Center for Oral Diseases of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou, China, 2. Key Laboratory of Molecular Medicine and Biotherapy, Department of Biology, School of Life Science, Beijing Institute of Technology, Beijing, China)

*Kathleen Frances Vincent1,2, Gwi H. Park1, Angel J. Cho1,3, David Obert1,2, Ken Solt1,2 (1. Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA, 2. Department of Anaesthesia, Harvard Medical School, Boston, Massachusetts, USA, 3. Touro College of Osteopathic Medicine, New York, New York, USA)

*Naotaka Izuo1, Daiki Ikejima1, Kakeru Chino1, Takashi Asano1, Tomoharu Kuboyama2, Chihiro Tohda3, Shin-Ichi Muramatsu4,5, Atsumi Nitta1 (1. Department of Pharmaceutical and Neuropharmacological Therapy, Faculty of Pharmaceutical Sciences, Graduate School of Medical and Pharmaceutical Sciences, University of Toyama, 2. Laboratory of Pharmacognosy, Daiichi University of Pharmacy, 3. Section of Neuromedical Science, Institute of Natural Medicine, University of Toyama, 4. Division of Neurological Gene Therapy, Open Innovation Center, Jichi Medical University, 5. Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo)

*Shuge Gui1, Fan Zeng2, Yicong Liu3,4, Junjun Ni5, Zhou Wu6,7 (1. Department of Oral and Maxillofacial Surgery, Faculty of Dental Science, Kyushu University, Fukuoka, Japan, 2. Shenzhen Key Laboratory of Immunomodulation for Neurological Diseases, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China, 3. The Affiliated Stomatology Hospital, School of Medical, Zhejiang University, Zhejiang, China, 4. Key Laboratory of Oral Biomedical Research of Zhejiang Province, School of Stomatology, Zhejiang University, Zhejiang, China, 5. Key Laboratory of Molecular Medicine and Biotherapy, School of Life Science, Beijing Institute of Technology, Beijing,China, 6. Department of Aging Science and Pharmacology, Faculty of Dental Science, Kyushu University, Fukuoka, Japan, 7. OBT Research Center, Faculty of Dental Science, Kyushu University, Fukuoka, Japan)

*Yuan Shi1,2,3, Mochen Cui1,2,4, Jochen Herms1,2,3 (1. Center for Neuropathology, Ludwig-Maximilians-Universität München, Munich, Germany, 2. German Center for Neurodegenerative Diseases (DZNE), Munich, Germany, 3. Munich Cluster for Systems Neurology (SyNergy), Munich, Germany, 4. Munich Medical Research School, Ludwig-Maximilians-Universität München, Munich, Germany)

[CINP2024] Poster Session

Addiction Disorders 4 - Clinical (2)

Sun. May 26, 2024 1:30 PM - 2:30 PM CINP Poster Session Hall (Lobby Gallery)

*Kah Kheng Goh1,2,3, Hu-Ming Chang4, Chenyi Chen3, Mong-Liang Lu1,2, Susyan Jou5, Vitor Hugo Jesus Santos6 (1. Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, 2. Department of Psychiatry, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, 3. Graduate Institute of Injury Prevention and Control, College of Public Health, Taipei Medical University, Taipei, Taiwan, 4. Department of Psychiatry, Taipei City Psychiatry Center, Taipei, Taiwan, 5. Graduate School of Criminology, National Taipei University, Taipei, Taiwan, 6. Department of Psychiatry and Mental Health, Cova da Beira University Hospital Center, Covilhã, Portugal)

*Yu-Li Liu1, Ming-Chi Huang2,3,4, Tung-Hsia Liu1, Hsiang-Wei Kuo1 (1. Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli County, Taiwan, 2. Department of Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan, 3. Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, 4. Psychiatric Research Center, Taipei Medical University Hospital, Taipei, Taiwan)

*Kai Zhang1,2,3, Yitan Yao1,2, Chuanchuan Chen1,3, Qiongyao Yang1,3, Yue Wang1,3, Miaomiao Zhang1,3, Wenhui Wang1,3, Yongjie Zhong1,3, Xiaoping Yuan1, Bei Luo4 (1. Chaohu Hospital of Anhui Medical University, Hefei, China, 2. Anhui Psychiatric Center, Anhui Medical University, Hefei, China, 3. School of Mental Health and Psychological Sciences, Anhui Medical University, Hefei, China, 4. Huzhou Third Municipal Hospital, Huzhou University, Huzhou, China)

STEFANIA CHIAPPINI1, GIACOMO D'ANDREA2, *CLARA CAVALLOTTO2, ALESSIO MOSCA2, FRANCESCO DI CARLO2, MAURO PETTORRUSO2, GIOVANNI MARTINOTTI2, FABRIZIO SCHIFANO3 (1. UniCamillus, 2. Department of Neuroscience, Imaging and Clinical Science, University G. D'Annunzio, Chieti, Italy, 3. Department of Clinical and Pharmaceutical Sciences, University of Hertfordshire, Hatfeld, UK )

*Elena Volkova1, Svetlana Valeryevna Gridneva2, Anna Ivanovna Tashcheva2, Vladimir Nikolaevich Egorov3, Oleg Arturovich Afrikian4 (1. Association of specialists on risk modification (ASMR), 2. Department of General and Pedagogical Psychology of the Academy of Psychology and Pedagogy of the Southern Federal University, Rostov-on-Don, Russia, 3. Department of Biology and General Pathology of the Don State Technical University, Rostov-on-Don, Russia, 4. PMI Science, Rostov-on-Don, Russia)

*Keisuke Asano1, Saeko Ikai-Tani2,3,4, Yohei Ohtani3, Hiroyuki Uchida3 (1. Department of Psychiatry, Inokashira Hospital, Tokyo, Japan, 2. Department of Psychiatry, Minami-Hanno Hospital, Saitama, Japan, 3. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 4. Faculty of Kinesiology & Physical Education, University of Toronto, Toronto, ON, Canada)

*Su Jeong Seong1, Jin Pyo Hong2, Bong-Jin Hahm3, Sung Man Chang4, Byung-Soo Kim4, Dong-Woo Lee5, Seong-Jin Cho6, Jong-Ik Park7, Jee Eun Park3, Hong Jin Jeon2 (1. Department of Psychiatry, Kangdong Sacred Heart Hospital, Seoul, South Korea, 2. Department of Psychiatry, School of Medicine, Sungkyunkwan University, Seoul, South Korea, 3. Department of Psychiatry, Seoul National University College of Medicine, Seoul, South Kore, 4. Department of Psychiatry, School of Medicine, Kyungpook National University, Daegu, South Korea, 5. Department of Psychiatry, Inje University College of Medicine, Seoul, South Korea, 6. Department of Psychiatry, Gachon Medical School, Incheon, South Korea, 7. Department of Psychiatry, Kangwon National University College of Medicine, Chuncheon, South Korea)

*Yuxin Zhang1,2, Xiao-Xing Liu1, Ming-Zhe Li1,2, Peng Li1, Yan-Ping Bao3, Lin Lu1,2 (1. Peking University Institute of Mental Health, Peking University Sixth Hospital, Beijing, China, 2. Peking-Tsinghua Centre for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, China, 3. Peking University Health Science Center, Peking University, Beijing, China)

*Arom Pyeon1, Ji-Won Chun2, Yeong Seon Jo1,3, Min Kyung Hu1, Dai Jin Kim1 (1. Department of Psychiatry, Seoul St. Mary's Hospital, College of Medicine, Catholic University of Korea, Korea, 2. Department of Medical Informatics, Seoul St. Mary's Hospital, College of Medicine, Catholic University of Korea, Korea, 3. Department of Psychology, Sungshin women’s university, Korea)

*Yeong Seon Jo1, Ji-Won Chun2, Arom Pyeon1, Min Kyung Hu1, Dai Jin Kim1 (1. Department of Psychiatry, Seoul St. Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea, 2. Department of Medical Informatics, Seoul St. Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea)

[CINP2024] Poster Session

Addiction Disorders 5 - Preclinical

Sun. May 26, 2024 1:30 PM - 2:30 PM CINP Poster Session Hall (Lobby Gallery)

*Wei Zheng1, Tangsheng Lu3, Yanxue Xue3, Lin Lu1,2,3 (1. Peking-Tsinghua Centre for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, 100871, China, 2. National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University Sixth Hospital, Peking University Institute of Mental Health, Beijing 100191,China, 3. National Institute on Drug Dependence, Beijing Key Laboratory of Drug Dependence, Peking University, Beijing 100191, China)

*Shinya Kasai1,2,3, Daisuke Nishizawa3, Susumu Higuchi4, Kazutaka Ikeda3 (1. Department of Biotechnology, Faculty of Life and Environmental Sciences, University of Yamanashi, 2. Center for Advanced Assisted Reproductive Technologies, University of Yamanashi, 3. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 4. National Hospital Organization Kurihama Medical and Addiction Center)

[CINP2024] Poster Session

Depression 5 - Clinical (3)

Sun. May 26, 2024 1:30 PM - 2:30 PM CINP Poster Session Hall (Lobby Gallery)

*SHIH KAI KEVIN LIN1, Hsi Chung Chen2,3, Chun Hsin Chen4,6,8, Yu Chu Ella Chung7, I Ming Chen2, Mong Liang Lu4,6,8, Cheng Dien Hsu5, Yi Hang Chiu4,6,8, Tsung Yang Wang2, Chih Ming Liu2, Ming Chyi Huang6,9, Shu I Wu10, Po Hsiu Kuo1,2,8 (1. Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan, 2. Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan, 3. Department of Psychiatry, Center of Sleep Disorders, National Taiwan University Hospital, Taipei, Taiwan, 4. Department of Psychiatry, Wan-Fang Hospital, Taipei Medical University, Taipei, Taiwan, 5. Department of Children and Adolescents Psychiatry, Taiwan Adventist Hospital, Taipei, Taiwan, 6. Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, 7. Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli, Taiwan, 8. Psychiatric Research Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, 9. Department of Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan, 10. Department of Psychiatry and Center for Suicide Prevention Mackay Memorial Hospital Taipei, Taiwan)

*Marcus Ising1, Petra Belcredi1, Susanne Lucae1, Alina Tontsch1, Christian Namendorf1, Manfred Uhr1, Florian Holsboer1, Monika Rex-Haffner1, Egle Simulionyte2, Sandi Hebib2, Oliver Gruber2, Nora Behler3, Tabea Nenov-Matt3, Cornelius Schüle3, André Manook4, Barbara Heckel4, Thomas Baghai4, Rainer Rupprecht4 (1. Max-Planck-Institute of Psychiatry, Munich, Germany, 2. Department of Psychiatry, Heidelberg University Hospital, Germany, 3. Department of Psychiatry and Psychotherapy, University Hospital LMU, Munich, Germany, 4. Department of Psychiatry, University Hospital, Regensburg, Germany)

*Naomichi Okamoto1, Takashi Hoshikawa1, Yuichi Honma2, Enkhmurun Chibaatar1, Atsuko Ikenouchi1,3, Masaru Harada2, Reiji Yoshimura1 (1. Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Fukuoka 8078555, Japan, 2. Third Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka 8078555, Japan, 3. Medical Center for Dementia, University Hospital, University of Occupational and Environmental Health, Fukuoka, Japan)

*clara cavallotto, Giacomo d'Andrea1, Andrea Miuli1, Carlotta Marrangone1, Rosalba Carullo1, Giovanna Mammarella1, Antonio D'Attilio1, Tommaso Piro1, Stefania Chiappini2, Alessio Mosca1, Francesco Di Carlo1, Mauro Pettorruso1, Giovanni Martinotti1 (1. Department of Neuroscience, Imaging, and Clinical Science, "G. d'Annunzio" University of Chieti-Pescara, Italy, 2. Unicamillus)

*Yohei Ohtani1, Hideaki Tani1, Kie Nomoto-Takahashi1, Taisuke Yatomi1, Kengo Yonezawa1, Sota Tomiyama1, Nobuhiro Nagai3, Keisuke Kusudo1, Shiori Honda1, Shinichiro Nakajima1, Tsuyoshi Eiro2, Tomoyuki Miyazaki2, Takuya Takahashi2, Hiroyuki Uchida1 (1. Keio University School of Medicine, 2. Yokohama City University Graduate School of Medicine, 3. Minami-Hanno Hospital)

*Jesper Henrik Lindahl1,2, Filip Ventorp1,2, Danielle van Westen3,4, Jimmy Jensen6, Johannes Björkstrand5, Daniel Lindqvist1,2 (1. Department of Clinical Sciences Lund, Psychiatry, Faculty of Medicine, Lund University, Lund, Sweden, 2. Office for Psychiatry and Habilitation, Psychiatric Clinic, Lund Sweden, 3. Department of Clinical Sciences Lund, Diagnostic Radiology, Faculty of Medicine, Lund University, Lund Sweden, 4. Image and Function, Skåne University Hospital, Lund Sweden, 5. Department of Psychology, Lund University, Lund Sweden, 6. Centre for Psychology, Kristianstad University, Kristianstad Sweden)

*Yanping Bao1, Tingting Liu1,2, Na Zeng1,5, Yingying Xu1,5, Tengteng Fan3, Shuyu Ni1,5, Yimiao Zhao1,5, Huan Mei1,5, Shuilin Wu1,5, Jie Shi1, Lin Lu1,3,4 (1. National Institute on Drug Dependence, Peking University, 2. Department of Pharmacy, Anqing Medical College, 3. Institute of Mental Health, National Clinical Research Center for Mental Disorders, Key Laboratory of Mental Health and Peking University Sixth Hospital, Peking University, 4. Peking-Tsinghua Center for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, Peking University, 5. School of Public Health, Peking University)

*Ekaterina Vladimirovna Gushanskaya1, Vladimir Ernstovich Medvedev2 (1. State budgetary healthcare institution “Psychiatric Clinical Hospital No. 13 of the Moscow Health Department”, Russia, 2. State budgetary healthcare institution “Psychiatric Clinical Hospital No. 13 of the Moscow Health Department”, Russia)

*Wang Han1, Lyu Nan1, Huang Juan1, Shang Li Li1, Zhao Qian1,2 (1. Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, 2. The Advanced Innovation Center for Human Brain Protection, Capital Medical University)

[CINP2024] Poster Session

Depression 6 - Translational

Sun. May 26, 2024 1:30 PM - 2:30 PM CINP Poster Session Hall (Lobby Gallery)

*Chemin Lin1, Shwu-Hua Lee2, Chih-Mao Huang3, Yu-Wen Wu4, You-Xun Chang4, Ho-Ling Liu5, Shu-Hang Ng6, Ying-Chih Cheng7, Chih-Chiang Chiu8, Shun-Chi Wu Wu4 (1. Department of Psychiatry, Keelung Chang Gung Memorial Hospital, Keelung City, Taiwan, 2. Department of Psychiatry, Linkou Chang Gung Memorial Hospital, Taoyuan County, Taiwan, 3. Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, Taiwa, 4. Department of Engineering and System Science, National Tsing Hua University, Hsinchu, Taiwan, 5. Department of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, Texas, 6. Department of Diagnostic Radiology, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, 7. Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan, 8. Department of Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan )

*Shuhei Ueda1,2, Masahito Hosokawa3,4,5, Manami Kakita1, Koji Arikawa4, Hiroko Matsunaga4, Haruko Takeyama3,4,5, Sayaka Takemoto-Kimura1,2 (1. Department of Neuroscience I, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan, 2. Molecular/Cellular Neuroscience, Nagoya University Graduate School of Medicine, Nagoya University, Nagoya, Japan, 3. Department of Life Science and Medical Bioscience, Waseda University, Tokyo, Japan, 4. Research Organization for Nano and Life Innovation, Waseda University, Tokyo, Japan, 5. Institute for Advanced Research of Biosystem Dynamics, Waseda Research Institute for Science and Engineering)

*Samar Salah Mohamedahmed Elsheikh1, Victoria Marshe2, James Kennedy1,3, Guillaume Paré4, Corinne Fischer5, Daniel Felsky1,3, Daniel Mueller1,3 (1. Center for Addiction and Mental Health, Toronto, ON, Canada, 2. Colombia University, New York, NY, USA, 3. University of Toronto, Toronto, ON, Canada, 4. McMaster University, Hamilton, ON, Canada, 5. St. Michael's Hospital, Toronto, ON, Canada)

*Xiaoyu Men1,2, Zachary L. Taylor3,4, Victoria S. Marshe5, Daniel M. Blumberger2,6, Jordan F. Karp7, James L. Kennedy2,6, Eric J. Lenze8, Charles F. Reynolds III9, Cristiana Stefan2,10, Benoit H. Mulsant2,6, Laura B. Ramsey3,4,11, Daniel J. Müller1,2,6 (1. Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada , 2. Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada, 3. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA, 4. Division of Clinical Pharmacology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA, 5. Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA, 6. Department of Psychiatry, University of Toronto, Toronto, ON, Canada, 7. Department of Psychiatry, The University of Arizona College of Medicine, Tucson, AZ, USA, 8. Department of Psychiatry, Washington University, St. Louis, MO, USA, 9. Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA, 10. Clinical Laboratory and Diagnostic Services, Centre for Addiction and Mental Health, Toronto, ON, Canada, 11. Division of Research in Patient Services, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA)

[CINP2024] Poster Session

Depression 7 - Others

Sun. May 26, 2024 1:30 PM - 2:30 PM CINP Poster Session Hall (Lobby Gallery)

*Eun-Gyoung Yi1,2,3, Miseon Shim6, Hyeon-Ho Hwang3, Sunhae Jeon3, Han-Jeong Hwang1,2, Seung-Hwan Lee3,4,5 (1. Department of Electronics and Information Engineering, Korea University , 2. Artificial Intelligence Smart Convergence Technology, Korea University , 3. Clinical Emotion and Cognition Research Laboratory, Department of Psychiatry, Inje University, 4. Psychiatry Department, Ilsan Paik Hospital, Inje University, 5. Bwave Inc, Goyang, 6. Department of Artificial Intelligence, Tech University of Korea)

*Yuri Ikeda-Matsuo1, Hina Takagi1, Yuta Kawabata1, Saki Iwato1, Asumi Doumae1, Shizuo Akira2, Satoshi Uematsu3, Tatsuo Takahashi1 (1. Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Hokuriku University, 2. WPI Immunology Frontier Research Center, Osaka University, 3. Department of Immunology and Genomics, Osaka Metropolitan University Graduate School of Medicine)

*Keira Joann Herr1, Michael Berk2, Wei-Lieh Huang3, Tadafumi Kato4, Jung Goo Lee5, Chong Guan Ng6, Zhen Wang7, Thomas Webb1, Mami Kasahara-Kiritani8, Lawrence Vandervoort9, Vince Grillo9 (1. Janssen Asia Pacific, Singapore, Singapore, 2. School of Medicine, Deakin University, Victoria, Australia, 3. Department of Psychiatry, National Taiwan University Hospital Yunlin Branch, Yunlin County, Taiwan, 4. Department of Psychiatry and Behavioral Science, Juntendo University Graduate School of Medicine, Tokyo, Japan, 5. Inje University Haeundai Paik Hospital, Busan, South Korea, 6. Department of Psychological Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia, 7. Shanghai Mental Health Center, Xuhui District, Shanghai, China, 8. Janssen Pharmaceutical K.K., Tokyo, Japan, 9. Cerner Enviza, Singapore)

[CINP2024] Poster Session

Obsessive-Compulsive Disorders

Sun. May 26, 2024 1:30 PM - 2:30 PM CINP Poster Session Hall (Lobby Gallery)

*Jia-Jia Zhou1, Qi-Hui Guo1, Gao-Yang Huang2, Zi-Jian Cheng1, Ru-Yuan Zhang1,2, Qing Fan1,3,4 (1. Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China, 2. Institute of Psychology and Behavioral Science, Antai College of Economics and Management, Shanghai Jiao Tong University, Shanghai, China, 3. Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China, 4. Mental Health Branch, China Hospital Development Institute, Shanghai Jiao Tong University, Shanghai, China)

*Seoyoung Kim1, Bo-Hyung Kim2, Euitae Kim 1,3,4, Jun Soo Kwon3,4,5 (1. Department of Neuropsychiatry, Seoul National University Bundang Hospital, Gyeonggi-do, Korea, 2. Department of Clinical Pharmacology and Therapeutics, Kyung Hee University Hospital, Republic of Korea, 3. Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea, 4. Department of Brain & Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea, 5. Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea)

[CINP2024] Poster Session

Childhood & Adolescent Disorders

Sun. May 26, 2024 1:30 PM - 2:30 PM CINP Poster Session Hall (Lobby Gallery)

*Benchalak Maneeton1, Prapinpatch Maneeton2, Yanisa Winichaikul3, Suttipong Kawilapat1, Nongluck Kienngam4, Narong Maneeton1 (1. Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand, 2. Chiang Mai University Demonstration School, Faculty of Education, Chiang Mai University, Chiang Mai 50200, Thailand, 3. Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand., 4. Department of Education Psychology and Guidance Program, Faculty of Education Chiang Mai University, Chiang Mai 50200, Thailand)

*Daisuke Hatta1, Kaito Kanamoto1, Shiho Makiya1, Kaori Watanabe1, Tatsuya Kishino2,5, Yuki Fuchigami3, Shigeru Kawakami3, Akira Kinoshita4,5, Koh-ichiro Yoshiura4,5, Naohiro Kurotaki4, Keiro Shirotani1,5, Nobuhisa Iwata1,5 (1. Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan, 2. Division of Functional Genomics, Research Center for Advanced Genomics, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan, 3. Department of Pharmaceutical Informatics, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan, 4. Department of Human Genetics, Atomic Bomb Disease Institute, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan, 5. Leading Medical Research Core Unit, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan)

*Moeka Tanabe1,2, Kazuo Kunisawa1, Imari Saito1, Aika Kosuge1, Hiroyuki Tezuka3, Tomoki Kawai1, Masaya Hasegawa1, Hisayoshi Kubota1,4, Kuniaki Saito2,5, Toshitaka Nabeshima2,6, Akihiro Mouri1,6 (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Sciences, Aichi, Japan., 2. Laboratory of Health and Medical Science Innovation, Fujita Health University Graduate School of Health Science, Aichi, Japan., 3. Department of Cellular Function Analysis, Research Promotion Headquarters, Fujita Health University, Aichi, Japan., 4. Division of Behavioral Neuropharmacology, International Center for Brain Science (ICBS), Fujita Health University, Aichi, Japan., 5. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Aichi, Japan., 6. Japanese Drug Organization of Appropriate Use and Research (J-DO), Aichi, Japan.)

*Mikio Yoshida1, Hikari Katada1, Yuya Isozumi1, Shunya Kawai1, Itaru Kushima2, Akira Yoshimi1, Norio Ozaki3, Yukihiro Noda1 (1. Division of Clinical Sciences and Neuropsychopharmacology, Meijo University, Faculty and Graduate School of Pharmacy, 2. Department of Psychiatry, Nagoya University, Graduate School of Medicine, 3. Pathophysiology of Mental Disorders, Nagoya University, Graduate School of Medicine)

*Misaki Iwahashi1,2, Takeshi Yoshimura1, Wakana Harigai1, Kazuhiro Takuma2,3, Hitoshi Hashimoto3,4,5,6,7, Taiichi Katayama1, Atsuko Hayata-Takano2,3,4 (1. Department of Child Development and Molecular Brain Science, United Graduate School of Child Development, Osaka University, Osaka, Japan, 2. Department of Pharmacology, Graduate School of Dentistry, Osaka University, Osaka, Japan, 3. Molecular Research Center for Children’s Mental Development, United Graduate School of Child Development, Osaka University, Osaka, Japan, 4. Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 5. Transdimensional Life Imaging Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka, Japan, 6. Division of Bioscience, Institute for Datability Science, Osaka University, Osaka, Japan, 7. Department of Molecular Pharmaceutical Science, Graduate School of Medicine, Osaka University, Osaka, Japan)

[CINP2024] Poster Session

Schizophrenia 5 - Clinical (3)

Sun. May 26, 2024 1:30 PM - 2:30 PM CINP Poster Session Hall (Lobby Gallery)

*CHUN-I LIU1, Yuan-Jen Tsai2, Kah Kheng Goh3,4 (1. Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan, 2. Department of Family Medicine, Taipei Medical University Hospital, Taipei, Taiwan, 3. Department of Psychiatry, Wan-Fang Hospital, Taipei Medical University, Taipei, Taiwan, 4. Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan)

*Nobuhisa Kanahara1,13, Kazuki Okada2, Yuji Otsuka3, Remiko Kobayashi2, Hiroshi Kimura4, Hiroshi Yamanaka5, Yuri Takaoki6, Taisuke Yoshida7, Takahiro Oiwa8, Fumiaki Ito9, Hiroshi Komatsu10, Takashi Ono11, Yuki Kikuchi12, Takahisa Saiga6, Shingo Noda13, Masaomi Iyo2 (1. Chiba University Center for Forensic Mental Health, Chiba, Japan, 2. Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan, 3. Department of Psychiatry, Asahi General Hospital, Asahi, Japan, 4. Department of Psychiatry, Gakuji-kai Kimura Hospital, Chiba, Japan, 5. Department of Psychiatry, Chiba Psychiatric Medical Center, Chiba, Japan, 6. Department of Psychiatry, Japanese Red Cross Narita Hospital, Narita, Japan, 7. Department of Psychiatry, Doujin-kai Kisarazu Hospital, Kisarazu, Japan, 8. Department of Psychiatry, Naoki-kai Isogaya Hospital, Ichihara, Japan, 9. Department of Psychiatry, National Hospital Organization Hanamaki Hospital, Hanamaki, Japan, 10. Department of Psychiatry, Tohoku University Hospital, Sendai, Japan, 11. Department of Psychiatry, Miyagi Psychiatric Center, Natori, Japan, 12. Department of Psychiatry, Yukou-kai, Kodama Hospital, Ishinomaki, Japan, 13. Department of Psychiatry, Ichihara-Tsuruoka Hospital, Ichihara, Japan)

*Mong-Liang Lu1,2,3, Kah Kheng Goh1,2, Tzu-Hua Wu3, Chun-Hsin Chen1,2 (1. Department of Psychiatry, Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan, 2. Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, 3. Department of Clinical Pharmacy, School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan)

*Yasushi Kawamata1,2, Norio Sugawara1,3, Taro Sasaki1,4, Saaya Yokoyama1,5, Hiroaki Okayasu1,6, Masataka Shinozaki1,7, Yoshitaka Takeuchi1,8, Aoi Sato1,9, Takaaki Ishikawa1,10, Hazuki Komahashi-Sasaki1,11, Kensuke Miyazaki12, Takashi Fukasawa13, Hanako Furukori14, Norio Yasui-Furukori1,3 (1. Department of Psychiatry, Dokkyo Medical University, School of Medicine, Tochigi, Japan, 2. Department of Psychiatry, Kikuchi Hospital, Tochigi, Japan, 3. Department of Psychiatry, TMC Shimotsuga, Tochigi, Japan, 4. Department of Psychiatry, Asahi Hospital, Tochigi, Japan, 5. Department of Psychiatry, Aoki Hospital, Tochigi, Japan, 6. Department of Psychiatry, Fudogaoka Hospital, Saitama, Japan, 7. Department of Psychiatry, Takizawa Hospital, Tochigi, Japan, 8. Department of Psychiatry, Okamotodai Hospital, Tochigi, Japan, 9. Department of Psychiatry, Muroi Hospital, Tochigi, Japan, 10. Department of Psychiatry, Saitama-Konan Hospital, Saitama, Japan, 11. Department of Psychiatry, Kanuma Hospital, Tochigi, Japan, 12. Department of Neuropsychiatry, Hirosaki-Aiseikai Hospital, Aomori, Japan, 13. Department of Psychiatry, Seinan Hospital, Aomori, Japan, 14. Department of Neuropsychiatry, Kuroishi-Akebono Hospital, Aomori, Japan)

*Ryotaro Kubota1, Satoru Ikezawa1,2, Hideki Oi3, Mari S Oba3, Shoki Izumi3, Leona Adachi1, Mako Miwa1, Ryoko Tsuno1, Shunji Toya4, Yohei Nishizato4, Daisuke Haga5, Tatsuro Iwane6, Kazuyuki Nakagome1 (1. Department of Psychiatry, National Center of Neurology and Psychiatry Hospital, Tokyo, Japan, 2. Department of Psychiatry, International University of Health and Welfare Mita Hospital, Tokyo, Japan, 3. Clinical Research and Education Promotion Division, National Center of Neurology and Psychiatry, Tokyo, Japan, 4. CNS Group, Medical Science, Sumitomo Pharma Co., Ltd., Tokyo, Japan, 5. One More Job Training Institution, Toyonaka, Osaka, Japan, 6. Kyoto Prefectural Rakunan Hospital, Kyoto, Japan)

*Yasaman Kambari1,2, Jianmeng Song1,2, Aron Amaev1,2, Ali Abdolizadeh1,2, Edgardo Torres-Carmona1,2, Fumihiko Ueno1,2, Teruki Koizumi1,2, John Rutka3, Emma LeBlanc3, Neil Bailie3, Wanda Dillon3, Kaitlin Harvey3, Laurel Palmer3, Ariel Graff-Guerrero1,2, Philip Gerretsen1,2 (1. Centre for Addiction and Mental Health (CAMH), Toronto, Ontario , 2. Institute of Medical Science, University of Toronto, Toronto, Ontario, 3. Toronto General Hospital, Toronto, Ontario)

*Akiko Harada1, Shilpa Madari2, Arvid Jungnik3, Kerstin Breithaupt-Groegler3, Kathrin Hohl3 (1. Nippon Boehringer Ingelheim Co., Ltd, Hyogo, Japan , 2. Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA, 3. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany)

[CINP2024] Poster Session

Schizophrenia 6 - Others

Sun. May 26, 2024 1:30 PM - 2:30 PM CINP Poster Session Hall (Lobby Gallery)

*Yoonjeong Jang1,2, Sanghyeon Park1,3, Hong-Hee Won3,4, Woojae Myung1,5 (1. Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seoul, South Korea , 2. Department of Health Science and Technology, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea, 3. Department of Digital Health, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center, Seoul, South Korea, 4. Samsung Genome Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 5. Department of Psychiatry, Seoul National University, College of Medicine, Seoul, South Korea)

[CINP2024] Poster Session

Personality Disorders

Sun. May 26, 2024 1:30 PM - 2:30 PM CINP Poster Session Hall (Lobby Gallery)

[CINP2024] Poster Session

Preclinical - Others (2)

Sun. May 26, 2024 1:30 PM - 2:30 PM CINP Poster Session Hall (Lobby Gallery)

*Tomohiro Tokutake1, Takashi Asano1, Naotaka Izuo1, Shin-Ichi Muramatsu2,3, Atsumi Nitta1 (1. Department of Pharmaceutical Therapy & Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Japan, 2. Division of Neurological Gene Therapy, Open Innovation Center, Jichi Medical University, Shimotsuke, Japan, 3. Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)

*Hirohito Esaki1, Kanta Imai2, Keisuke Nishikawa2, Shoma Izumi1, Ayumu Inutsuka3, Kazuki Nagayasu4, Shuji Kaneko4, Naoya Nishitani1,2, Satoshi Deyama1,2, Katsuyuki Kaneda1,2 (1. Laboratory of Molecular Pharmacology, Institute of Medicine, Pharmaceutical, and Health Science, Kanazawa University, 2. Laboratory of Molecular Pharmacology, School of Pharmaceutical Science, Kanazawa University, 3. Division of Brain and Neurophysiology, Department of Physiology, Jichi Medical University, 4. Department of Molecular Pharmacology, Graduate School of Pharmaceutical Science, Kyoto University)

*Shoma Izumi1, Hirohito Esaki1, Naoya Nishitani1, Kazuki Nagayasu2, Shuji Kaneko2, Satoshi Deyama1, Katsuyuki Kaneda1 (1. Laboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan., 2. Department of Molecular Pharmacology Graduate School of Pharmaceutical Sciences Kyoto University, Kyoto, Japan.)

*Hsiang-En Wu1, Shao-Ming Wang2,4, Chun-Yu Lin3,4, Fenf-Ju Weng2,4, Hsuan-Cheng Wu2,4, Leeodella Sands1, Tsung-Ping Su1 (1. Cellular Pathobiology Section, INRB, IRP, NIDA, NIH, 2. Graduate Institute of Biomedical Sciences, China Medical University, Taiwan, 3. School of Medicine, China Medical University, Taiwan, 4. 4Neuroscience and Brain Disease Center, China Medical University, Taiwan)

*Simon Couly1, Yuko Yasui1, Semnyonga Foncham1, Ioannis Grammatikakis2, Ashish Lal2, Lei Shi3, Tsung-Ping Su1 (1. Cellular Pathobiology Section, Integrative Neuroscience Research Branch, Intramural Research Program, National Institute On Drug Abuse, NIH/DHHS, 333 Cassell Drive, Baltimore, MD, 21224, USA., 2. Regulatory RNAs and Cancer Section, Genetics Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), Bethesda, MD, 20892, USA., 3. Computational Chemistry and Molecular Biophysics Section, Molecular Targets and Medications Discovery Branch, National Institute On Drug Abuse, NIH/DHHS, 333 Cassell Drive, Baltimore, MD, 21224, USA.)

*Somrudee Saiyudthong1, Kosum Chansiri2, Brian Lee3, Phakkharawat Sittiprapaporn, Kanchanapa Sathirachawan1 (1. Department of Physiology, Faculty of Medicine, Srinakrarinwirot University, Bangkok, Thailand, 2. Department of Biochemistry, Faculty of Medicine, Srinakharinwirot University, Bangkok, Thailand, 3. Department of Internal Medicine, Faculty of Medicine, Srinakrarinwirot University, Bangkok, Thailand)

*Daisuke Nishizawa1, Ryozo Morino2, Rie Inoue1,3, Seii Ohka1, Shinya Kasai1, Junko Hasegawa1, Yuko Ebata1, Kyoko Nakayama1, Hiroyuki Sumikura3, Masakazu Hayashida1,3, Miyuki Yokota4,5, Kazutaka Ikeda1 (1. Department of Psychiatry and Behavioral Sciences (Addictive Substance Project), Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 2. Division of Anesthesiology, Koujinkai Daiichi Hospital, Tokyo, Japan, 3. Department of Anesthesiology and Pain Medicine, Juntendo University School of Medicine, Tokyo, Japan, 4. Department of Anesthesiology, Cancer Institute Hospital, Tokyo, Japan, 5. Department of Anesthesiology, East Hokkaido Hospital, Kushiro, Japan)

[CINP2024] Poster Session

Others (2)

Sun. May 26, 2024 1:30 PM - 2:30 PM CINP Poster Session Hall (Lobby Gallery)

*Eri Takeuchi1, Michihiro Imamura1, Takefumi Kikusui2, Masayuki Sekiguchi1,3, Yoshitsugu Aoki1 (1. Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 2. School of Veterinary Medicine, Azabu University, 3. Laboratory of Pharmacology, Faculty of Pharmaceutical Science, Tokyo University of Science)

*Tsung-Hsuan Hung1,2, Tsung-Yu Tsai3, Ching-Ju Chiu4 (1. Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan , 2. Education Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 3. Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. , 4. Institute of Gerontology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.)

×

Authentication

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

×

Please log in with your participant account.
» Participant Log In